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INTRODUCTION
The entire pancreatic output of insulin is secreted into the
portal venous blood which then passes through the liver before reaching
the systemic circulation.

During a single transhepatic passage, 40-50%

of the insulin is removed (47, 133, 202, 236, 237).

Regulation of both

hepatic and peripheral glucose metabolism is dependent on insulin.
Therefore, hepatic extraction and degradation of insulin may be important determinants in the control of glucose homeostasis.
Past investigations of the liver's role in insulin regulation
treated it as a homogeneous organ composed of only parenchymal cells
(47, 57, 63, 64, 88, 116, 133, 155, 173, 194, 202, 209, 215, 219, 232,
233, 236, 237, 252, 318, 319, 322, 325, 327, 336, 337, 338, 339, 340,
361).

However, the liver contains several types of cells with the

following approximate percent distribution:

60.6% parenchymal cells,

33.4% RES or reticuloendothelial system cells, 2.0% bile duct cells,
1.8% endothelial cells and 2.0-5.0% connective tissue or fat (vitamin A)storing cells (31, 122, 317).

Thus, 40% of the cells are non-parenchy-

mal and of these the Kupffer cells of the RES are in the majority,
making them a numerically significant cell population.
The
of the

Ku~ffer

he~atic

cells are tissue or fixed macrophages which form part

sinusoidal lining.

Because of their location, the

Kupffer cells are in intimate contact with the pancreatic insulin
percolating through the liver.

Depression of RES endocytic function

carbon blockade (36), lead (143, 330) or endotoxin (20, 23, 179, 192,

by

2

323) has resulted in changes in glucose regulation (52, 55, 56, 79, 84,
87, 140, 142, 144, 145, 146, 188, 225, 263, 272, 290, 291, 292, 303,
363, 364).

Besides their highly active endocytic processes, the Kupffer

cells, like all macropi1ages, also carry out numerous metabolic, degradative and secretory functions {7, 8, 73, 113, 127, 210, 239, 240, 264,
265, 268, 276, 310, 311).

Therefore, the Kupffer cells may play a role

in hepatic insulin regulation.
The purpose of this study was to investigate the relationship
between altered RES endocytic function, especially of the hepatic Kupffer cells and insulin regulation.

In order to alter RES function, two

models of RES depression, acute lead treatment (143, 330) and colloidal
carbon blockade (36), were utilized in male rats.

Functional evidence

regarding the insulin status of the animals was studied by determination
of the susceptibility to insulin-induced hypoglycemic convulsive death
and iv glucose tolerance testing.

Finally, both basal and glucose-

stimulated serum insulin and glucose levels were measured.

--LITERATURE REVIEW
The Reticuloendothelial System
Several attempts have been made to classify phagocytic mononuclear
cells and to define the cell system which they form.

During the 1880's,

Metchnikoff first demonstrated the role of certain phagocytic cells in
host cellular immunity (24, 158, 276).

In his studies, he emphasized

that ingestion and destruction of foreign bacteria

by the "macrophage

system were essential metazoan disease defense mechanisms (24, 276).
11

Later Ribbert and Nagoa and other workers found that intravenously
injected colloidal dyes or India ink were intensely localized in phagocytic cells lining blood sinuses in the liver, spleen and bone marrow
(7, 196, 244, 276).

Subsequently, in 1924, Aschoff introduced the term

.. reticuloendothelial system

11

(RES) to describe a body of mesenchymal-

derived cells forming a diffuse system of wandering and fixed macrophages having in common the physiological function of rapid ingestion and
storage of foreign colloidal or particulate matter (7, 276).

Aschoff

included the reticulum and endothelial cells of the lymph nodes, spleen
and bone marrow, the endothelial cells lining the sinuses in the adrenal
cortex and anterior pituitary, blood histiocytes or monocytes and connective tissue macrophages (7, 268).
name "reticulohistiocyte system

11
,

Volterra and Thomas proposed the

which included all cells that could

acquire the "histiocytic state" of enhanced metabolic activity, cell
proliferation and growth, as well as the powers of motility and phagocytosis (158).

Their system included bone, muscle, epithelial and Schwann
3

4

cells in addition to those which Aschoff had placed in the RES (158).
Unfortunately, true endothelial and reticulum cells are not phagocytic rendering the terms RES and reticulohistiocyte system misnomers
(59).

In 1969, a new classification of the monocyte-macrophage system

was proposed, the 11 mononuclear phagocyte system 11 or MPS (59, 158, 159,
210, 229).

Cells were included in the MPS on the basis of similarities

of morphology, function, origin and kinetics of phagocytosis (158).
Only

11

professional 11 phagocytes having immunoglobulin and complement

receptors at the cell surface, the ability to attach to glass and avid
phagocytic and pinocytic processes were included (158).

The MPS cur-

rently is comprised of bone marrow precursor cells, blood monocytes,
microglial cells of the nervous system and connective tissue, liver,
lung, lymph node, bone marrow and pleural and peritoneal macrophages
{159).

In this thesis the older name

11

reticu1oendothelial system" is

used since it is still the most popular, with the understanding that
only the blood monocytes and macrophages are being discussed.
Monocyte-r·1acroohage Morpho 1OCJY
Mononuclear phagocytes are descendants of hemopoietic stem cells
(159, 229), not of mesenchymal elements as are the fibroblasts, reticulum and endothelial cells (159).

Within the bone marrow, the committed

stem cell gives rise to the monoblast, which undergoes mitosis and
differentiates into the promonocyte (158, 159, 210, 229).

Promonocytes

divide to form monocytes which are released into the blood for transportation to the tissues where further maturation and transformation takes
place resulting in the formation of the tissue macrophages or histio-

5

cytes (153, 210,301,321, 345).
Monocytes leave the circulation and are transformed into macrophages via various morphological and functional changes.
ing monocyte is a large 10-15

~m

The circulat-

diameter cell with an indented or

'·

reniform nucleus having prominent nucleoli, numerous mitochondria and
lysosomes and a well-developed Golgi apparatus and rough endoplasmic
reticulum (158, 210).

Monocytes can undergo mitosis (320).

Like tissue

macrophages, monocytes phagocytose, adhere to glass and show cytoplasmic
spreading (210).
(210).

Locomotion is promoted by undulating cytoplasmic veils

Immunoglobulin G (IgG) receptors, instrumental in phagocytosis,

have been found on the cell membrane (320).

The half-time of disappear-

ance of monocytes from the circulation has been calculated to be 22
hours (268).
After arrival at the tissues, the monocytes become avidly phagecytic macrophages having increased numbers of cytoplasmic granules,
vesicles and lysosomes (268, 320).
diameters of 10-40

~m

These cells are larger with reported

with either an oval or reniform nucleus and in-

creased endoplasmic reticulum (16, 153, 268).
infrequently may be stimulated to undergo
358).

Mature tissue macrophages

mitosis~

situ (212, 213, 268,

In chronic inflammatory states, macrophages have been demonstrated

to have increased lysosomal enzymes and plasma membrane with hypertrophy
of the Golgi apparatus, all characteristics of "stimulation" or "activation'' (2, 210).

Studies have shown that macrophages have a dynamic mem-

brane system which, as a result of repeated endocytosis, requires replenishment of plasma membrane and synthesis of new primary lysosomes
(120, 354, 355).

Recently Emeis has reported that liver Kupffer cells

6

possess a two-layered cell coat composed of an outer filamentous protein
layer and an inner layer of glycoproteins or glycolipids which may be
important in endocytosis (121,
of IgG

an~

123)~

Receptors for both the Fe portion

the third component of complement (C3) also have been found

on the macrophage cell membrane (2.]0, 246, 310). The cytoplasm contains
a cytoskeletal system of microtubules and also microfilaments, reported
to be composed of the contractile proteins actin and myosin, which may
be instrumental for phagocytosis (73, 188, 246,312, 3-13). The life span
of tissue macrophages is long; it has been estimated to be from 60 days
to several years (210).
Endocytosis
As discussed above, macrophages have been classified as a cell
system because of their fundamental ability to engulf material from
their external environment (7, 24, 59, 158, 159, 210, 229, 276).

Mono-

nuclear phagocytes are the only cells which exhibit all three types of
endocytosis:

phagocytosis, macropinocytosis and micropinocytosis (159).

Endocytosis involves an invagination of the plasma membrane with subsequent fusion to form vacuoles (174, 242, 266) which may fuse with each
other prior to transportation to the Golgi or peri-nuclear region where
they fuse with either primary or pre-existing secondary lysosomes and
are themselves converted into secondary lysosomes (72, 73, 351).

These

fusions are selective, involving only membrane derived from the plasmalemma or Golgi apparatus (73).

The molecular mechanisms of membrane

fusion have not been clarified but defective fusion of vacuoles and
lysosomes has been shown to occur following ingestion of virulent

7

tubercle bacilli, viable toxoplasma, symbiotic algae (73), polymeric
dextran sulfate (113) and concanavalin A (73, 110, 111), a lectin (293).
Failure of degranulation or fusion of primary lysosomes with phagosomes
also has been reported in human monocytes with the hereditary ChediakHigashi syndrome (310).

The three types of endocytosis, phagocytosis,

macropinocytosis and micropinocytosis (2, 210, 240, 268, 275, 313) have
been shown to involve different sized particles, membrane events and to
have different metabolic requirements (2, 70, 113, 210, 240, 268, 275,
310, 311, 313).
It has been suggested that the term "phagocytosis" should be
restricted to the uptake of

particles~

1

~min

Stossel has divided phagocytosis into 7 events:

diameter (2, 210, 313).
1) recognition of the

particle surface by the phagocyte; 2) the phagocyte receives the message
of recognition; 3) the phagocyte relays this message to its cytoplasm;
4) effector mechanisms are aroused which cause the phagocyte to adhere
to the particle; 5) pseudopods are induced to assemble; 6) and move
around the particle, and; 7) the tips of pseudopods fuse at the distal
side of the particle (311).

How the macrophage recognizes a particle

to be phagocytosed is unclear.

Several theories have proposed that

particles are ingested on the basis of molecular properties such as
surface hydrophobicity, net surface charge or perhaps surface tens ion
forces (8, 73, 311).

In 1903, Wright and Douglas demonstrated that

normal human serum contained a substance that stimulated bacterial phagocytosis, \vhich they called an "opsonin" (276).

Investigators have

also found opsonic activity in other vertebrate plasma and sera (150,

8

153, 248, 264, 309).

Some have considered the opsonins to be specific

IgG or a fragment of C3 (242, 310, 311) while others have believed that
opsonins may be "natural antibodies" possibly a-globul-ins (276, 277, 279,
280, 309):

Opsonic activity has been reported to be increased by heparin

'·

(147, 148, 149, 150, 264, 276).

The binding of the particle, which may

be opsonized, has been shown to occur at specific receptors, including
those for the Fe portion of lgG and C3 (210, 246, 310, 311 ).

Chemical

or mechanical events within the membrane have been suggested to transmit
the receptor binding "message" to the effector mechanism

causes

~vhich

the phagocyte to adhere to the particle to be ingested (311).

Stossel

has proposed that the cell surface contact causes the assembly and
activation of cytoplasmic actin and myosin, present in microfilaments,
which may then result in movement of the pseudopods around the particle
or ingestion (310, 311, 312, 313).

The energy needed for phagocytosis

is provided by the anaerobic glycolytic path\vay with the exception of
alveolar and hepatic macrophages

~1hich

also depend on oxidative metabo-

lism (2, 8, 208, 210, 264, 265).
"Pinocytosis" refers to the cellular uptake of particles
diameter with their fluid medium (210, 268, 313).

<

1 wn in

This process has

been further divided into "macropinocytosis" which produces vacuoles
0.3-2.0

~m

in diameter that are visible by phase contrast microscopy and

"micropinocytosis" \vhich produces 70-100 nm diameter "microvesicles"
demonstrable only by electron microscopy (2, 210, 240, 268).

Pinocytic

vesicles have been seen to flow centripetally in the cell, apparently
guided by microtubules (73, 231 ).

Pinocytosis is still an obscure

process and involvement of specific cell membrane receptors has been

9

proposed but not proven (240, 275).

Although a single particle can

trigger phagocytosis, it is now thought that a number of particles must
accumulate on a given area of cell surface for pinocytosis to occur
(268).

Cohn and Parks have demonstrated that adenosine and ATP as well

as certain anionic proteins,

carbohydra~es,

amino acids and nucleic

acids increase macropinocytosis by mouse macrophages (71, 76, 77, 268).
Serum has also been shown to induce pinosome formation in mouse macrophages (70, 78, 113, 231), particularly newborn calf serum which contains an anti body to mouse ce 11 membranes (2, 71, 72, 78, 113).

In-

creased pinocytic activity has been demonstrated to result in increased
lysosome formation (113).

Inhibitors of protein synthesis, glycolysis

and oxidative phosphorylation have been shown to block macropinocytosis
(2, 70, 71, 72, 113).

Micropinocytosis, on the other hand, has been

reported to be more resistant to metabolic inhibitors and appears to be
inhibited by low temperatures when there is less membrane fluidity (2,
240).

Cytochalasin 8, a fungal metabolite which interferes \'Jith micro-

filament function, inhibits phagocytosis (312) and macropinocytosis (2)
but is ineffective in blocking micropinocytosis (2, 240).

It should be

noted that in the early RES literature, all endocytic acts were commonly
labeled phagocytosis or phagocytic clearance despite the fact that the
particles were often

<

1

~m

in diameter, as in the case of colloidal

gold, 30 nm (268, 309) or colloidal carbon 25 nm (36, 180, 309, 359).
Lewis had discovered pinocytosis in mammalian cells in the 1930's but
this term was considered to apply only to the cellular uptake of fluid
with dissolved substances (113).

10
RES endocytic activity has been

evaluated~

vivo by the intra-

vascular clearance method (20, 21, 36, 179, 276, 309).

Various test

particles have been utilized including colloidal carbon, colloidal gold,
saccharated iron oxide, denatured serum albumin, lipid emulsions, latex
beads, foreign red blood cells, silicon dioxide and chromium phosphate,
as well as isotopically labeled colloids (20, 21, 36, 37, 179, 276,
Benacerraf et

~-

309~

have described the characteristics of a good test

particle preparation as follows:

the particles should 1) be phagocy-

tosed by RES cells in contact with the blood, 2) not cross capillary
walls, 3) be homogeneous in size, 4) stable in the blood, 5) be nontoxic for the RE cells or the organism, 6) be accurately measurable in
blood or tissues, and 7) be cleared only by the cells of the RES (21,
179, 276).

Another criterion, added by Saba, is that the functional

status of theRE cells be the rate-limiting factor, i.e., the availability of plasma opsonic factors should not be compromised by an
excessive dose of test material (21, 276, 309).

However, Stiffel et al.

have emphasized that phagocytosis of larger organized particles such as
bacteria or red cells is dependent on serum opsonin concentration in
contrast to endocytosis of simple colloids (309).

The test dose should

also be large enough to not be rate-limited by hepatic blood flow (276).
Kinetics studies have demonstrated that the test particle clearance is
exponential in nomal circumstances, allovJing the calculation of a halftime of disappearance
time and the equation k

(t~)

by a semilog plot of concentration versus

= 0.639/t~

or by the equation K =

0.301/t~

where

K is the "phagocytic index" and K = k x 0.4343 (20, 21, 36, 179, 276,
309).

It has been demonstrated that 70-96% of a test dose is localized

11

in the hepatic Kupffer cells with most of the remainder found in the
spleen (36, 179, 276) 309). Similar types of phagocytosis studies measuring the extraction of colloidal carbon, colloidal radiogold, radioiodinated albumin aggregates, REtest lipid emulsion and opsonized sheep
red cells have also been done in vitro in both the isolated perfused rat
liver and isolated rat Kupffer cells (8, 148, 150, 153, 239, 264, 279).
The Conceot of RES Blockade
The classical method for evaluation of the physiological role of
an organ or system is its surgical removal.

Ho~tJever,

the diffuse nature

of the RES made this impossible, so 11 blockade 11 techniques were devised
in which depression of RES phagocytic function was caused by injection
of a large dose of foreign particulate matter such as colloidal carbon,
(12, 20, 21, 22, 36, 38, 103, 179, 205, 213, 243, 259, 309), lead ace-

tate (143, 288) and many other types of colloids, particles and ernulsions (12, 20, 21, 38, 90, 179, 212, 243, 278, 309, 343, 359). In vitro
blockade studies have also been done using foreign blood cells in rat
and mouse Kupffer cells (239, 301).

After the colloidal or particulate

overload, a state of decreased endocytic activity has been observed for
a variable period of time which is the blockade state (12, 20, 21, 22,
36, 38, 103, 143, 179, 205, 213, 248, 259, 276, 278, 301' 309, 359).

Blockade was then followed by a recovery or even a slight increase in
phagocytic function (22, 38, 90, 103, 205, 212, 213, 259, 301, 309, 343).
Several explanations for the phenomena of blockade and recovery
have been put forth.
11

Classically, blockade was thought to be due to a

physical saturation'' of theRE cells which resulted in reduced cellu-

lar clearance of particles with similar surface characteristics (20, 21,

36, 179, 243, 247, 309, 359).

12
More recently the idea that the increased

endocytic activity produces a depletion of opsonins has also been presented since addition of opsonic substances reversed a state of phugocytic depression (248, 277, 278, 309).

Although the depletion of opsonins

could be ihstrumental in causing RES depression, other investigators
have reported that the limiting factors for endocytic activity seem to
be the amount of plasma membrane internalized and the cytoplasmic volume of the cell, with recovery of endocytosis occurring only after
synthesis of nev1 membrane (73, 239, 301, 354, 355).

Recovery from

blockade has also been demonstrated to occur by local cellular proliferation and hypertrophy (90, 196, 212, 213, 243) or by replenishment of
cells from a bone marrow source (301).
f~onocyte-Nacrophage

Substrate

t~etabol

i srn

Mononuclear phagocytes have a dynamic intracellular metabolism
which must provide substrates and energy for both ongoing cellular
activities and sudden bursts of endocytic activity.

The intracellular

metabolic activity is dependent on several factors including stage of
cellular maturation, specific tissue location,
tosis (210).

11

activation

11

and endocy-

The bone marrow monocyte precursor cells have an active

glycolytic pathway (210).

Maturation into blood monocytes and tissue

macrophages is accompanied by augmentation of glucose consumption and
lactate production (210).

Hexose monophosphate shunt, aerobic metabol-

ism and cellular respiration are present but less prominent (210, 214).
With increased development of intracellular organelles, there is an
increase in protein synthesis and a corresponding elevation of lysosomal
enzyme activities (210).

Specific details regarding macrophage glucose,

13

lipid and amino acid-protein metabolism and their relationship to the
specific cell type and functional status will be discussed belov1.
The macrophage possesses an active glucose metabolism which has
been the subject of numerous studies.

Several investigators have re-

ported that both alveolar (165) and peritoneal macrophages (45, 238)
accumulate glucose by a facilitated diffusion transport system.

In

the alveolar macrophage, this system was inhibited by theophylline and
was insulin independent (165).

This is in contrast to early studies

on mixed leukocyte populations which reported both an 1!!_ vitro and in
vivo insulin stimulation of glucose uptake and lactate production (108,

126).

Phagocytosis augmented glucose transport in peritoneal macro-

phages by lowering the

~n

value (45).

Kupffer cells, peritoneal and inflammatory exudate macrophages have
been shown to contain glycogen stores (131, 175, 176, 269).

Interesting-

ly, the wandering macrophage appeared to maintain these stores in two
ways:

1) via a glycogen synthetase which was found to exist in 2 forms,

either independent of or dependent on glucose-6-phosphate for activity

(176) and 2) by uptake of extracellular or exogenous glycogen from incubation media (175, 176), or from glycogen shed from neutrophils into
exudative fluids (269) or by direct transfer by mononuclear neutrophil
cellular apposition (269).

Although 1!!_ vivo insulin treatment increased

glycogen synthesis in human leukocytes (126), it had no effect when added to peritoneal macrophages 1!!_ vitro (174).

The glycogen pool of peri-

toneal macrophages 1!!_ yitro \.'/as observed to be very labile and readily
depleted by incubation in glucose-free media and by phagocytic activity

(174, 176).

T\<'!O

glycogen degradative systems are also present in the

peritoneal macrophage:

14
1) a glycogen phosphorylase system and 2) an

a-1,4 glucosidase of probable lysosomal origin (176).

Glycolysis seems to be a universal method of energy production in
mononuclear phagocytes (8, 70, 208, 210, 214, 264); however, the reliance on this pathway may be affected by the microenvironment of the cell
(210).

The alveolar macrophage, which is chronically exposed to high

oxygen levels, has been demonstrated to utilize oxidative phosphorylation as its primary energy source in contrast to the peritoneal macrophage (208, 210).

Several workers have emphasized that both pinocytosis

and phagocytosis are dependent on glycolysis in monocytes and peritoneal,
hepatic and alveolar macrophages since they were inhibited by glycolytic
inhibitors (2, 8, 70, 208, 210, 264).

During phagocytosis, peritoneal

macrophages have also demonstrated great increases in Krebs cycle activity and smaller increases in hexose monophosphate shunt activity (2, 208).
Alveolar and hepatic macrophages which normally utilize oxidation of
glucose and the hexose monophosphate pathway (8, 210, 264, 265, 268)
did not show such a marked elevation in oxidative metabolism during
Glucose oxidation in iso-

phagocytosis (8, 208, 210, 264, 265, 268).

lated Kupffer cells has also been found to be non-responsive
addition of insulin (264).

''Activation 11 is a phenomenon

to~·vitro

~·Jhich

results

in increased cell size and enhanced macrophage phagocytic digestive and
microbicidal activity (210).

Activated or

11

elicited 11 macrophages have

been found to possess increased size and number of lysosomes, elevation
in acid hydrolases, an enlarged Golgi zone and increased plasma membrane
ruffling as well as an increased glucose oxidation (208, 210).

Activa-

tion has been induced by exposure to various agents which include
caseinate (208) thioglycollate, bacterial lipopolysaccharide, immune

15
complexes and facultative intracellular bacteria (210).
In addition to their continuous utilization of glucose, macrophages also carry on a dynamic lipid metabolism.
gation

ha~

been divided into 3 research topics:

This area of investi1) cellular synthesis

and oxidation of fatty acids and triglyceride synthesis and degradation,
2) the relationship between macrophages and atherosclerosis including
cholesterol and lipoprotein metabolism and 3) the tremendous lipid turnover of the cell membrane following endocytosis.
et

~-

Two studies by Pisano

demonstrated that isolated rat Kupffer cells oxidize exogenous

acetate to co 2 (264, 265) and that this oxidation decreased during phagocytosis (265), suggesting that marcophages might possess a significant
fatty acid metabolism.

Both hepatic and peritoneal macrophages have
been shown to oxidize l- 14 c-palmitate (91, 264). Rabbit peritoneal and
alveolar macrophages also oxidized 14c-labeled triglycerides (91, 118)
implying the existence of a lipolytic system.

Elsbach found a high

lipase activity in rabbit alveolar macrophages and obtained evidence
that lipolysis preceded uptake of glycerides which were then esterified
in the cell (118).

Other histochemical and biochemical studies have

indicated that macrophages possess both cytoplasmic esterase and lipase
activity (92).

Alveolar macrophages also incorporated free fatty acids

complexed to albumin or in chylomicrons into cellular lipids; this incorporation was suppressed by the addition of glycolytic inhibitors
(118).

Macrophages have also been shown to synthesis fatty acids and

mono-, di- and triglycerides from acetate (93, 210).
et-al.
-

Recently, Wagle

have reported that epinephrine, but not glucagon, stimulated

lipolysis of triolein and tripalmitin by isolated rat Kupffer cells

(34~.
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A nunber of early observations implicated a role for the RES in the
uptake of triglycerides, cholesterol, phospholipids and lipoproteins.
Many of those experiments were done using artificial triglyceride emulsions

whic~ ~\lere

suggested,

readily ingested by Kupffer and other RE cells and

therefor~

that the

Ku~ffer

cells might remove lipid from the

circulation and transfer it to the liver parenchymal cells (92, 304).
However, as mentioned above, macrophages do metabolize the lipid they
take up (91, 92, 118).

Additionally it was found that Kupffer cells

handled artificial emulsions differently than biological lipoproteins
(92), possibly because the emulsions were recognized as foreign and
because lipids from chylomicrons

~vere

taken up directly by the paren-

chymal cells (92).
Cholesterol, a component of lipoproteins, has been shown to accumulate

in RE cells after oral, ip or iv administration (1, 33, 92, 94,

107) and in Tangier Disease, a genetic deficiency of heavy-density lipoprotein or HDL (195).

Macrophages also internalized cholesterol from

in vitro incubation media (33, 91, 92, 355).

Despite one isolated report

of macrophage synthesis of cholesterol from acetate (93), it is generally
thought that macrophages do not synthesize it and rely on the external
medium as their sole source of cholesterol (210, 354, 355).
peritoneal macrophages could not oxidize cholesterol (91 ),

Rabbit
supporting

other studies which demonstrated active macrophage cholesterol esterification (92, 93, 94, 95).

Normally cholesterol esters are not further

metabolized, but are stored in the cell (83, 92, 94, 195) and excluded
from incorporation into cellular membranes (83).
Drevon

~ ~-,

A recent study by

however identified the presence of a lysosomal cholesterol
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esterase in hepatic macrophages which hydrolyzed cholesterol esters
contained in HDL (106) . .II!_ vivo, cholesterol, free or esterified, is
normally transported within plasma lipoproteins because sterols are
virtually insoluble in aqueous media (83).

It has been hypothesized

that free cholesterol is then incorporated into cell membranes by
exchange diffusion from the lipoproteins (83).

Once in the cell, the

free cholesterol equilibrates between the plasma and organelle membranes
(83).

There may also be an endocytic uptake of lipoproteins by macro-

phages as has been implicated in fibroblasts and other cells (48, 49).
Brown and Goldstein have proposed that low-density lipoproteins (LDL)
first bind to a cell surface receptor, leading to endocytosis of the LDL
with lysosomal protease hydrolysis of the protein component to amino
acids, released from the cell, and hydrolysis of the cholesterol ester
component by a lysosomal lipase, with the resulting unesterified cholesterol being incorporated into cell membranes (48, 49).

They have also

suggested that the level of LDL presented to the cell has a negative
regulatory influence on the synthesis of LDL receptors (48, 49).

Kupffer

cells have been suggested to be a site of LDL catabolism (245); uptake of
HDL has been demonstrated in hepatic macrophages (106).

Concanavalin A

inhibited cholesterol ester uptake by hepatic nonparenchymal cells,
suggesting the presence of a carbohydrate-containing lipoorotein binding
site ( l 06).
Knowing about the macrophage's propensity for lipid uptake, it
should be no surprise that many investigators found lipid-laden macrophages or "foam cells" at the sites of atherosclerotic plaque formation
(1, 82, 92, 107, 183).

Histological studies verified that these foam
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cells were of two types, lipid-containing macrophages and smooth muscle
cells, in the intimal layer of arterial blood vessels
183).

Adams et

~.,demonstrated

(1

~

82, 92, 107,

the sclerosing effect of cholesterol

on connective tissue and that phospholipid promoted macrophage uptake
of cholesterol (1).

They interpreted this as evidence of a protective

role of macrophages in removing tissue-irritating cholesterol aggregates
(1).

As was mentioned above, macrophages tended to accumulate chole-

sterol esters (91, 92, 94, 106) which seemed in turn to promote deposition of other plasma or newly synthesized lipids in macrophages lining
the arterial wall (92).

These cells are then taught to die, leaving a

sequestered pool of interstitial lipids, forming the gruel-like core of
the plaque (82, 183).

When exposed to an increased cholesterol-phos-

pholipid ratio, such as occurs with ingestion of a cholesterol-rich,
atherogenic diet, mammalian cells tend to accumulate cholesterol in
their membranes (83).

Cooper has hypothesized that the formation and

storage of cholesterol esters occurring in atherosclerosis may be an
adaptive process designed to divert the cholesterol to a form excluded
from cell membrane structure, preventing deleterious changes in fluidity
(83).

In fact a decrease in membrane fluidity due to an increase in the

membrane ratio of cholesterol to phospholipid content has been associated
with a decreased endocytic ability in macrophages (83).
During a bout of endocytic activity, a macrophage may internalize
50-60% of its plasma membrane (73, 354), resulting in an increased lipid
turnover (268).

Surface lgG receptors and 5'-nucleotidase present on

the plasma membrane also have been found to disappear after phagocytosis
(239, 285, 354, 355).

After such maximal endocytosis, cells rounded up

19

and ceased both pinocytic and phagocytic activity for 5-6 hours (73,
355).

Over this period of time, biochemical changes suggesting syn-

thesis of new membrane occurred including increased RNA, protein and
phospholip~d

synthesis and a net increase in membrane RNA, protein and

phospholipid synthesis and a net increase in membrane cholesterol (73,
119,

120, 210, 354, 355).

Plasma membrane synthesis required the pre-

sence of exogenous cholesterol and was blocked by inhibition of protein
and RNA synthesis (354, 355).

The increased membrane synthesis does

not occur at the site of vacuole formation but is only evident 6 hours
after endocytosis (210, 354).

Macrophages have been shown to synthesize

phospholipids from labeled acetate (93), choline (354) and lysolecithin
(120).

Phospholipids containing labeled choline have been localized in

plasma membrane and secondary lysosomes; they have also been shown to be
exchanged between cytomembranes via a specific cytosolic protein (210,
354).

The amount of new membrane synthesized has been reported to be

linearly related to the amount of membrane initially internalized (73)
with quantitative restoration of its original composition (354).
After formation of an endocytic vacuole, there is fusion of the
membrane resulting in a pinosome or phagosome lined with the plasma
membrane constituents which were originally on the exterior of the cell
(73).

Subsequent fusion of the vacuole with lysosomes leads to discharge

of acid hydrolases and digestion of endocytized macromolecules, including
membrane polypeptides, to small molecular weight products (73, 113).
Thus plasma membrane molecules such as 5'-nucleotidase, phosphodiesterase
and IgG receptors have been observed to disappear following endocytosis,
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only to be replaced later (73, 239, 285, 354, 355).

Macrophages are

capable of nucleic acid synthesis, both RNA and DNA, (210, 212, 213,
268) and possess a well-developed endoplasmic reticulum for protein
synthesis (210, 268).

The replacement of membrane components has been

shown to occur after RNA and protein synthesis (73, 354, 355).

Indue-

tion of lysosomal enzymes and increased formation of lysosomes has also
been noted in response to endocytic activity (113, 354). Cohn ~t ~-·
followed the intracellular flow of 1eucine-H3 in mouse peritoneal macrophages (75). They found that there is initial labeling of the rough
endoplasmic reticulum, followed by appearance of the label in the Golgi
complex and finally the dense granules contained the majority of the
isotope and suggested that lysosomal hydrolytic encymes are synthesized
in the endoplasmic reticulum and then transferred to the Golgi apparatus
where the enzymes are packaged into small Golgi vesicles resulting ih
formation of primary lysosomes (75).
Alveolar macrophages have been shown to possess carrier-mediated
transport systems for adenosine and lysine (30, 332, 354).

These trans-

port sites were apparently preserved after 35-50% of the membrane was
internalized since constancy of transport activity did not depend on
production of new transport sites (332).

A role for microtubules in

maintaining a separation of the transport and phagocytic sites has been
suggested (30, 246, 332, 354).

This preservation of amino acid and

nucleotide transport during endocytosis seems appropriate for the
succeeding bout of protein synthesis.

However, a recent report present-

ed evidence that protein synthesis and leucine transport were inhibited
in suspended alveolar macrophages after repeated \'lashing, perhaps by the
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removal of a necessary surface membrane RNA (334).
Besides synthesizing proteins to maintain their cellular integrity,
macrophages synthesize and secrete many other proteins.

Macrophages, as

discussed previously, actively synthesize lysosomal enzymes which have
been reported to be released outside the cell during endocytosis (2, 73,
89, 96, 127, 210, 224, 230, 299, 310,352).

Only about 10-15% of the

total cellular lysosomal acid hydrolase activity appeared extracellularly
(73).

In contrast, 85-90% of the enzyme lysozyme was secreted indepen-

dent of cellular activity (73, 127) and may be a major macrophage secretory product (73).

Another enzyme, plasminogen activator, which is

involved in lysis of fibrin and cleavage of complement proteins and
Hageman factor via conversion of plasminogen to plasmin, was secreted
primarily by activated macrophages (73, 127).

Synthesis of collagenase

and elastase for export has been observed (127, 230, 349).

Macrophages

have been shown to synthesize serum complement proteins Clq, C2, C3, C4,
and C5 (71, 115, 127, 210, 230, 305, 306) as well as transferrin (125,
210, 305, 306).

Production of a variety of proteins related to immuno-

logical functions by macrophages such as colony-stimulating factor, interferon and lytic, stimulatory or inhibitory factors has also been
demonstrated (89, 127, 210, 230, 249, 275, 320).

After phagocytosis,

macrophages, especially Kupffer cells have been reported to produce the
protein endogenous pyrogen (9, 19, 42, 43, 102, 127, 171, 178, 210, 351)
which may or may not be related to leukocytic endogenous mediator, a
protein synthesized and released by macrophages and blood leukocytes (19,
206, 260).

Two recent reports have even implicated macrophages in regu-

lation of the renin-angiotensin system by production of angiotensin-
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converting enzyme (156, 222).

Thus, the secretory function of macro-

phages gives the RES the potential to exert a regulatory influence on
its environment within the organism and to function almost as an endocrine organ.
Metabolic Role of the RES in the Organism
Aschoff in his studies on the RES was obviously aware of the important role of macrophage metabolism in the organism when he proposed the
name
(7).

11

histiocytic metabolic apparatus 11 as an alternate title for the RES
The macrophages have been implicated in many catabolic and trans-

formation reactions such as drug metabolism and detoxification (100, 276)
and, as discussed above, in lipoprotein and cholesterol transformation
and metabolism (1, 7, 20, 33, 91, 92, 93, 94, 95,106,107, 118, 245, 276,
354, 355).

Berliner demonstrated that adrenal cortical RE cells are

involved in cortisol production from progesterone while the hepatic RE
cells clear steroids and cause steroid ring A reduction preparatory to
excretion (31, 32).

Thyroxine degradation during bacterial phagocytosis

has also been reported (98).

A relationship between RE cell activity and

transcobalamin II metabolism has been suggested (167).

Macrophages seem

to regulate the clotting system by several routes since they produce
plasminogen activator (73, 127) and have been demonstrated to clear both
fibrin aggregates (220) and thromboplastin (302).
Some of the earliest known RES functions were the sequestration and
destruction of aged, foreign or damaged red blood cells and circulating
hemoglobin with subsequent bile pigment or bilirubin formation and conservation of the heme iron in ferritin (7, 20, 72, 125, 159, 160, 239,
268, 276).

The globin moiety of hemoglobin is degraded by proteases and
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the heme by heme oxygenase (320).

Iron stored as ferritin is trans-

ported back to erythroid precursors via the protein transferrin, secreted
by the macrophage (102, 125, 210, 306).

Transferrin molecules have been

proposed to,_ deliver the iron to the cell surface of the erythroid precursors and return empty to theRE cells to pick up another load (125,
320).
as

11

Others have suggested that macrophages in the bone marrow serve

nurse 11 cells in an island of developing cells, supplying iron by

transferrin or by direct ce11-to-ce11 delivery (125, 320).
RE cells are very active in removal and degradation of effete,
autologous tissue, antigens and proteins by means of their extensive
array of lysosomal enzymes {2, 25, 74, 89, 111, 113, 210, 224, 241, 276,
352).

Macrophages have been shown to arrive at the site of inflammation

later than polymorphonulcear leukocytes (89, 137, 224).
appear to function as

11

The macrophages

Scavenger 11 cells, phagocytizing fibrin and cellu-

lar debris in preparation for repair (224).

Several in vitro studies

have demonstrated macrophage segregation and digestion of radiolabeled
serum albumin, bovine gamma globulin, hemoglobin, horse radish peroxidase and polypeptides in secondary lysosomes (20, 71, 72, 111, 112, 113).
Apparently the macrophages digested the proteins down to the level of
amino acids (71, 72, 113).

Chronic inflammatory conditions can be per-

petuated by macrophage release of lysosomal enzymes, collagenase, elastase, cytotoxic activities, prostaglandin release and activation of
clasts (127, 168, 224, 230, 349, 351, 352).

o~teo-

Macrophages may also help

in elimination of unwanted protein by secreting proteolytic enzymes
during absorption of the tadpole tail during metamorphosis and the period
of collagen resorption in the post-partum uterus (96,

127).

Experi-
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mental absence of macrophages led to an increased amount of fibrin
debris and a slowing of fibrinogenesis in wounds (127).

Rebuck et

~.,

also discussed the phenomenon of leukocytic glycogen transfer to macrophages at tcnflammatory sites (269).

Both Cohn (74) and Gudewicz (175,

176) found that macrophages possess enzymes of probable lysosomal origin
capable of hydrolyzing a-lined polysaccharides.

Macrophage a-1,4 glu-

cosidase activity may provide an additional source of glucose via endocytosed glycogen not only to the inflammatory macrophage but to other
cells at the site since a portion of this glucose is released to the
outside (175, 176).
The cells of the RES tend to accumulate phagocytizable organic
material when it is present in the body in amounts that cannot be rapidly disposed of by normal catabolic or excretory processes such as in
storage diseases or conditions with excessive cell turnover and death
(74, 96, 159, 320, 351).

Hemosiderosis, asbestosis, silicosis and xan-

thomas are examples of storage diseases caused by macrophage endocytosis
of nondigestible materials (159).

Inborn genetic enzyme deficiencies

can result in macrophage lysosomal enzyme deficiency storage diseases
characterized by the presence of undigested material in the lysosomes
(74, 159, 320, 351).

Cohn was able to induce a similar disorder in vitro

by allowing mouse peritoneal macrophages to pinocytose sucrose or Ficoll,
a polysucrose (74).

Interestingly, antigenic substances, for example,

a-globulins and keyhole limpet hemocyanin, may bypass extensive catabolism by either remaining bound to the plasma membrane or undergoing only
partial degradation and processing for release from the cell to stimulate
lymphocyte function (85, 210).
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Since the time of Metchnikoff, the role played by the RES in host
cellular immunity by clearance of potentially harmful bacteria and
viruses from the body has been emphasized (14, 20, 38, 58, 89, 179, 196,
263, 276, 487).

The RES has also been considered to be instrumental in

the clearance of endotoxin, the lipopolysaccharide component of gram
negative bacterial cell walls having a molecular weight of about 1 million, normally preventing a fatal shock episode (18, 20, 23, 41, 44, 53,
101, 129, 171, 179, 192, 196, 274, 276, 323, 350, 353, 370).

Bona found

that macrophages appeared to take up endotoxin by pinocytosis (44).
Macrophages have been shown to detoxify endotoxin via lysosomal activity
or perhaps by elaboration of a blood antiendotoxin system (135, 136, 137,
138, 139, 141, 329, 353).

It has long been known that the acute admini-

stration of endotoxin to an animal results in depression of RES function
(20, 23, 179, 192, 323).

This RES depression may be the result of the

profound alterations in glucose metabolism caused by endotoxemia (52,
54, 55, 56, 79, 87' 134, 140, 145, 146, 188, 225, 263, 272, 290, 291,
292, 303, 363, 364).
RES - Hormone Interactions
In prior sections of this review, several instances of RES interaction with various segments of the endocrine system were mentioned.
Although the RES does participate in the metabolism and synthesis of
hormones and in turn RES functions are affected

by certain hormones, the

elucidation of this area of RES physiology has only begun.

Some of the

earliest observations concerned the effects of estrogens on the endocytic
function of the RES.

It is generally believed that the female mammal is
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more resistant to stress than the male.

This belief has not been

systematically investigated; however, it has been suggested that the
female hormones, especially the estrogens, may stimulate RES function
and thus increase cellular immunity (4).

In 1935, Nicol found that

'

estrogenic hormones seemed to induce the formation and stimulate the
activity of guinea pig uterine macrophages (316).

Several investigators

reported that phagocytic activity increased during the two peak levels
of estrogen present during the human menstrual cycle and in the estrous
cycle of lower mammals (316, 342).

Ovariectomized rodents showed

decreased phagocytic activity with a decline in the number of uterine
macrophages (342).

Estrogen replacement increased the number of macro-

phages in spayed animals (342).

During the early implantation and late

stages of pregnancy, RES endocytic activity is elevated (316, 342).
Ovariectomy reduced survival against highly virulent infections (342).
In the rat, females were reported to have greater ability to clear
colloidal carbon and greater resistance to lethal circulatory trauma (4).
In male rats, estrogen treatment conferred trauma resistance and caused
hyperactivity of the RES (4).

Thus, in general, estrogenic steroids have

an unequivocal st-imulatory effect on RES endocytic activity (4, 179, 316,
342).

Several mechanisms for this stimulation have been presented

including an increased migration of mononuclear cells from the bone
marrow (331, 342), local cellular proliferation, especially in the liver
(342), higher phagocytic activity of the available macrophages (342) and
an elevated rate of energy metabolism, especially of hexose monophosphate
shunt activity (214, 342).
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Another group of steroids, the adrenal corticosteroids also have
profound effects on the RES.

Patients with Cushing's syndrome, charac-

terized by an excess of corticosteroids or with Addison's disease and a
lack of corticosteroids both showed increased susceptibility to infection
{316).

Pharmacological doses of cortisone also were known to reduce the

resistance of man and animals to bacteria, viruses, fungi and bacterial
toxins (22, 38, 316, 342).

Therefore, experiments were done to determine

the reasons for the impairment of immunity, particularly of the phagocytic function of the macrophages.

Heller reported that cortisone admini-

stration depressed RES colloid clearance in both rats and mice (186,
316).

Others reported no effect of cortisone on the basic RES endocytic

activity (21, 22).

Cortisone administration did delay the recovery phase

following colloidal blockade (22, 179, 316) and suppressed the normal
stimulatory reaction of the RES to bacterial products (38).

Insight into

the mechanism by which corticosteroids influence RES kinetics was provided by studies on inflammation (130, 324).

In normal mice, subcutane-

ous injection of corticosteroids resulted in a rapid drop in the number
of blood monocytes released from the bone marrow (324) and inhibition
of macrophage accumulation in sites of inflammation (130).

It is likely

then that corticosteroids do not modify the phagocytic properties of
macrophages

~ ~

(130).

In contrast to the above findings, smaller

doses of cortisone reportedly stimulated RES phagocytic activity (316,
342).

This is consistent with the report that cultured peritoneal macro-

phages required cortisol in the culture medium to maintain normal functions such as serum protein synthesis (156, 306).

Altura has also found

that glucocorticoids prevented the early RES depression seen in circula-
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torY shock (3).

Yet the same small doses of cortisone which enhanced

RES endocytic activity inhibited macrophage digestive and bactericidal
capacities (130, 342).

This last effect may be the result of cortico-

steroid inhibition of degranulation (130, 310) and stabilization of
lysosomes (224, 351).

It is now accepted that small doses of cortico-

steroids maintain or enhance RES function while large doses depress it
(99, 342).

It should be reiterated that adrenal cortical macrophages

produce cortisol from progesterone while hepatic Kupffer cells clear
steroids and cause ring A reduction preparatory to conjugation and
excretion (31, 32).

Thus macrophages also have a role in regulation of

steroids which in turn influence their activity.
Because of the known interactions of the RES and adrenal corticosteroids, studies were done to ascertain the effects of hypophysectomy
on RES function (35, 99, 211).

DiCarlo et

~-

found that hypophysectomy

did not affect the rate of phagocytosis in mice (99).

However, others

found that long term effects of this operation included a progressive
fall in RES phagocytic capacity (35, 211) possibly due to a decrease in
RES mass and blood volume (211).

Although Keefe

et~.

found that zyrno-

san-induced stimulation was still possible after pituitary removal in
rats (211 ), DiCarlo et

~-

could not cause RES stimulation in hypophy-

sectomized mice unless they were treated with ACTH (adrenocorticotropin),
pituitary suspension or corticosterone (99).

The latter group hypothe-

sized that ACTH may be stimulatory to the RES via increased adrenal cortical secretion (99).
Bilder noted both thyroidectomy and hypophysectomy decreased the
RES maximum phagocytic rate or V111.ax (35).

She attributed this effect to
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the resulting decrease in thyroid hormone since thyroxine treatment
restored Vmax to intact levels (35).

The thyroid hormones may maintain

RES function by regulating v1hole body metabolism (35) rather than by a
direct effect, as proposed by Stambul (204).
~Joeber

Recently DeRubertis and

demonstrated the uptake and metabolism of thyroxine by hepatic

macrophages during Samonella tyohimurium sepsis in monkeys (98).

They

proposed that thyroxine could influence the host phagocytic cell function (98).
In addition to metabolizing hormones or being affected by them, macrophages also produce hormone-like substances which influence the secretion of endocrine glands.

Besides adrenal cortical macrophage participa-

tion in glucocorticosteroid production (32), macrophages have been shown
to release large quantities of prostaglandins (168, 230).

Rabbit alveo-

lar macrophages, exposed to physiological concentrations of corticosteroids, contained increased levels of angiotensin converting enzyme

(15~,

suggesting that the RES may influence the regulation of blood pressure.
In macrophage related diseases, such as Gaucher's disease, increased macrophage production of serum angiotensin converting enzyme has also been
observed 056, 222).

After l.!!_ vivo stirilulation with bacteria, macrophages

have been shown to produce leukocytic endogenous mediator, a protein produced by leukocytes, which causes a shift of amino acids from muscle to
liver, increased hepatic amino acid uptake, cAMP levels and glycogenolysis as well as elevation of plasma insulin and glucagon levels with host
hypoglycemia

09,

166, 206, 260). Therefore, the macrophages may regulate f)an-

creatic insulin and glucagon levels and the host's metabolic responses
to infection (166).

Moore et al. have likewise demonstrated that macro-
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phages exposed to endotoxin produced an anti-gluconeogenic substance
which inhibited corticosteroid induction of phosphenolpyruvate carboxykinase (235), an insulin-like effect.
Classically the effects of hormones affecting hepatic metabolism
were thought to occur only at the parenchymal cells.

This generalization

is no longer valid since the identification of a hormone sensitive adenylate cyclase in Kupffer cells (270, 347, 348, 362).

Despite one report

of glucagon-sensitive adenyl cyclase being located in the RE cells (270),
studies on isolated cells demonstrated that epinephrine sensitive adenylate cyclase predominated (347, 348, 362).

Wincek and coworkers found

that Kupffer cell adenylate cyclase was stimulated by fluoride ion, GTP
and catecholamines as monitored by cAMP production (362).

Wagle et

~

demonstrated that epinephrine, but not glucagon, stimulated hepatic
macrophage lipolysis (348).

The latter group also claimed that both

epinephrine and, to a lesser extent glucagon stimulated gluconeogenesis
in Kupffer cells (347, 348); however, these results could be due to
parenchymal cell contamination.
Because Kupffer cells are responsive to catecholamines and glucagon,
and by inference possess "receptor sites" for these hormones, it seems
reasonable to investigate the effect of insulin on Kupffer and other RE
cells.

Initially, the increased susceptibility to infection seen in

diabetics (10) sparked interest in this topic.

Several immunodeficien-

cies have been identified in human diabetics including decreased or
missing antibody formation to bacterial antigens (223), possibly due to
inhibition of lymphocyte blastogenesis, as was reported in diabetic rats
(256), decreased numbers of peripheral T-lymphocytes (60) and impaired
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leukocyte migration (161).

Several workers also noted depressed phago-

cytosis by granulocytes and macrophages in the diabetic state (10, ll,
105, 269).

Yet Berken and Sherman found that RES phagocytosis was

normal in diabetes (27) and Gabrieli and associates found it to be
abnormally accelerated (161).

The discrepancies in these results have

been explained by the direct correlation between successful blood glucose management with insulin and the return to normal phagocytic function (10, 11, 27).

Apparently the elevated blood glucose levels and

hypertonicity depressed phagocytosis (67, 105, 283, 310).
using his

11

Rebuck et a 1 .

skin window 11 technique demonstrated that diabetics did show a

defective inflammatory response which he attributed to a failure of
leukocytic glycogen transfer to mononuclear phagocytes (269).

Neutro-

phils from severely diabetic patients, in that study, showed abnormally
high glycogen concentrations accompanied by decreased neutrophil migration and phagocytosis in contrast to cells from well-controlled diabetics
and controls which shed their glycogen to lymphocytes, monocytes and
macrophages (269).
Still other investigators sought to further characterize the effect
of insulin directly on white blood cells and macrophages.

Dumm studied

the effect of insulin on glucose utilization by mixed white blood cells
and reported increases in cells from both normal and diabetic subjects
after

both~

vivo insulin administration

of insulin (108).

and~

vitro using 0.1-0.5 U/ml

Esmann, also saw a slight in vitro insulin effect on

glucose uptake by human leukocytes with l U/ml and a 4 hour incubation;
no effect was observed on glycogen synthesis (126).

Studies specifically

on macrophage glucose metabolism yielded similar results since insulin
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had no effect on glucose transport in alveolar macrophages (165) or on
peritoneal macrophage glycogen synthesis (174).

Kupffer cell glucose

oxidation was also unaffected by insulin (264).

Generally speaking,

insulin seemed to have no effect on macrophage glucose metabolism.
The apparent leukocyte insensitivity to insulin puzzled investigators since mixed leukocytes had been reported to bind large amounts of
insulin compared to other tissues (184) and binding was similar in normal
and diabetic cells (296).

Gavin, Archer and their coworkers subsequently

demonstrated that circulating and cultured B-lymphocytes contained specific insulin binding sites (163, 164).

However, a study by Krug et

~·

detected no such receptors on resting lymphocytes; it is very likely that
they had a T-lymphocyte cell population (217).
ed to be present on the T-cell only

after~

Insulin receptors appear-

vitro transformation with

concanavalin A (217) or after immune activation (185, 315).

Insulin

caused an augmentation ofT-lymphocyte cytotoxicity (185, 315) and in
another study, it increased both glucose transport and membrane ATPase
activity in human lymphocytes (177).
consequences in lymphocytes.

Thus insulin binding had functional

Gavin and coworkers also reported that

chronic (5-16 hr) exposure of cultured human lymphocytes to insulin resulted in a reduction of insulin receptor concentrations, suggesting a
reciprocal relationship between the amount of insulin in extracellular
fluid and the number of insulin receptors per cell which directly affects
target-cell hormone sensitivity (164).

Lymphocytes were then utilized

in several studies for investigation of possible insulin receptor binding
defects to explain the conditions of insulin resistance (5), diabetes
(253) and obesity (6).
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In a study on insulin receptors on human mononuclear leukocytes,
Swartz and associates demonstrated that although lymphocytes constituted

80% of these cells, the amount of
bound

corr~lated

1 2 5I-labeled

insulin specifically

significantly only with the number of monocytes (286).

Autoradiograms of blood smears also showed that only monocytes bound the
labeled insulin (286).

.l\pparently many of the experimenta 1 11 lymphocyte 11

preparations were contaminated with monocytes and thus showed insulin
binding and likewise no binding if measures were taken to insure depletion of monocytes (185).

Monocytes were then immediately used to further

investigate the disorders of obesity (251) and diabetes (254, 255).
Diabetes mellitus and obesity were both accompanied by decreases in insulin receptor number (250, 254).

The use of circulating monocytes was

instrumental in ident-ifying a cause for the diabetic syndrome of acanthosis nigricans in which patients show a marked resistance to insulin
probably due to the presence of insulin receptor antibodies (154, 203,

204) or a decrease in binding affinity (204).

Recently, Thorsson and

Hintz reported that monocytes also possess specific receptor sites for
the insulin-like substance somatomedin (325).
Since the discovery of monocyte insulin receptor binding, investigators have endeavored to find some associated biological functions in
RES cells.

One of the earliest observations on a possible effect of

insulin was in a study by Stossel

~! ~-

on phagocytosis (314).

Although

that study utilized polymorphonuclear leukocytes, it is significant to
note

that~ ~itro

addition of insulin at a physiological concentration

of 2 mU/ml slightly stimulated the phagocytic rate (314).

In a later

report, Rhodes demonstrated that guinea pig peritoneal macrophage Fe
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receptor expression is modulated by insulin and cyclic nucleotides (271).
In both human monocytes and mouse spleen macrophages, insulin inhibited
antibody-dependent cytotoxicity (13) possibly by decreasing the number
of Fe receptors (271).

Therefore, macrophages appear to possess func-

tionally significant specific insulin receptors.

Several groups, work-

ing independently, demonstrated that peripherally injected

l31I

or

1 2 5I-

insulin tended to be localized in hepatic Kupffer cells (17, 307, 366),
as did injected insulin-antibody complexes (157).

Chandler and Varandani,

working with a mixed blood leukocyte population, have identified the
insulin-degrading activity present as the enzyme glutathione-insulin
transhydrogenase (65).

Additionally, both glutathione-insulin transhy-

drogenase and insulin specific protease were found in the lysosomal
fraction of rat liver (173).

Because Kupffer cells are rich in lysosomes

and lysosomal enzymes (25, 241, 299) and are in intimate contact with
pancreatic insulin secreted into the hepatic portal circulation and
possess active secretory, metabolic and degradative processes, it is
possible that Kupffer cells may participate in the modulation of insulin
activity in the organism.
The Effect of RES Depression on Glucoregulation and Shock

S~sceptibility.

Since it was known that the RES played a significant role in the
removal of pathogenic organisms and endotoxin, which if left unchecked
could produce a shock type of death, studies were conducted to determine
if blockade of the RES by other substances could increase shock susceptibility.

Depression of the RES by saccharated iron oxide, thorotrast,

large doses of cortisone or whole body irradiation increased the inci-
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dence of death from traumatic or endotoxin shock (142, 152, 227, 369).
Similarly lead acetate treatment also sensitized rats to death by endotoxin shock (79, 80, 81, 135, 143, 288, 329).

Interestingly, stimula-

tion of RE.S function by zymosan, endotoxin, estrogens or induction of
trauma resistance decreased susceptibility to shock death (4, 151, 192,
369' 371).
RES depression by colloidal carbon blockade has also been demonstrated to cause alterations in glucose regulation as judged by 1) the
enhanced hypoglycemic response to insulin, 2) increased insulin-induced
hypoglycemic lethality, 3) decreased gluconeogenesis and 4) increased
total body glucose oxidation (142, 144).

Lead administration has also

been shown to cause decreased gluconeogenesis and increased hypoglycemic
response to insulin

(52, 84, 140).

Endotoxemia and gram negative sep-

sis also depress the RES (20, 23, 179, 192, 323) producing similar but
more profound changes in glucose homeostasis along with changes in insulin activity (26, 55, 56, 79, 86, 87, 142, 145, 146, 172, 188, 189,
225, 263, 272, 290, 291, 292, 303, 363, 364) suggesting that the RES
governs the host metabolic response to endotoxin not only by clearance
of bacteria and endotoxin but by modulating insulin levels.

Considera-

tion of the above date indicates a probable relationship between RES
functionaf status and insulin regulation.

Statement of Purpose

-------------

The purpose of this study was to investigate the relationship between
altered RES endocytic function and insulin regulation.

In specific,

experiments were performed:
1.

to investigate the effect of RES depression, using acute lead

acetate administration, on susceptibility to insulin-induced hypoglycemic
convulsive death;
2.

to evaluate the influence of RES depression on iv glucose toler-

ance and;
3.

to ascertain the effect of RES depression by either colloidal

carbon blockade or acute lead treatment on actual basal and glucosestimulated serum insulin levels as measured by the Phadebas radioimmunoassay.
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METHODS
A.

Animals
Ad~lt

male albino Holtzman rats (Madison, Wisconsin) were used in

all experiments.

The rats were housed 3-5 per cage and allowed to

acclimate to our animal quarters which were kept at 26-28°C with a 12
hour light-dark cycle--lights on at 7 a.m. and off at 7 p.m. (Central
Standard Time) for 7-15 days prior to use.

Rats were given Purina Labo-

ratory Rat Chow (Ralston Purina Co., St. Louis, Missouri) and tap water
ad

libitu~

until approximately 4 p.m. the afternoon preceding experi-

ments when only the food was removed to allow for an overnight fast of
about 18 hours.

The rats weigl1ed 302

~

25 grams (mean + standard devi-

ation, N ~ 353) on the day of the experiments.

B.

Acute Lead Treatment
In order to alter RES function, acute administration of lead

acetate (PbAc) 5 mg/300 g rat was utilized since this dose has been
shown to depress RES phagocytic function-(143,330). Powdered lead acetate
(Code 5684, Mallinckrodt Chemical Works, St. Louis, Missouri) was prepared in deionized distilled water to a concentration of 5 mg/ml on the
day of the experiment.

Depending on the experiment protocol, control

treatment consisted of 1 ml of either 0.9% pyrogen-free saline (Travenol
Laboratories, Inc., Deerfield, Illinois) or a 5 mg/ml solution of sodium
acetate (NaAc) (Code 7372, Mallinckrodt) in deionized distilled water.
~ats

received the l ml injection iv via the dorsal vein of the penis
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under light ether anesthesia (Anesthesia Grade, Mallinckrodt) induced
in a glass ether jar.

c.

Colloidal Carbon Blockade
As a second method of RES depression classic colloidal carbonblock-

ade (36) was induced by iv injection of 32 mg/100 g body weight of colloidal carbon.

An inert biological ink was used--Pelikan Special Ink,

Cll/143la (Gunther-Wagner, West Germany, Koh-I-Noor Radiograph, Inc.,
Bloomsbury, New Jersey) which is a colloidal suspension of homogeneous
25 nm carbon particles (36, 180, 359) stabilized in a 4-5% fish glue
gelatin solution (147, 247) with 1% phenol as a preservative (36, 152).
To standardize the carbon concentration, the ink stock was diluted
1:10,000 with deionized distilled water or 0.9% saline to permit densimetric determination of 3 ml aliquots using 1 x 1 em cuvettes in a Beckman Model DU Spectrophotometer (Beckman Instruments, Inc., Fullerton,
California) at a wavelength of 675 nm.

The conversion factor of 0.04

OD U/mg carbon per liter (147) allowed calculation of the carbon concentration which was 83.5 mg/ml which is in agreement with the reported
concentration of approximately 100 mg/ml (36).
For blockade induction, the ink was diluted 1 part ink to 1.6 parts
0.9% non-pyrogenic saline (Travenol) to achieve a concentration of
32 mg/ml, pH adjusted to 7.4 and kept refrigerated until shortly before
use.

A sham blockade vehicle control for the ink diluent was obtained

by ultracentrifugation of the ink at 25,000 x g in an International
Preparatory Ultracentrifuge Model B-35 (International Equipment Co.,
Needham Heights, Massachusetts) which produced a supernatant that was
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diluted as the carbon, oH

=

7.4 and refrigerated.

Sham and carbon

solutions were prepared the evening before or day of the experiment.
In carbon blockade experiments, the rats were separated into 3 groups.
One group received a slow 3 ml iv injection of the 32 mg/ml colloidal
carbon or 32 mg/100 g under light ether anesthesia.

The 2 control

groups were a sham vehicle group that was iv injected with 3 ml of the
sham and an uninjected control group.
D.

Insulin Lethality Experiments
Overnight fasted rats were divided into two groups, one

received the

non~lethal

dose of 5 mg PbAc iv, the other pyrogen-free

isotonic saline under light ether anesthesia.

Immediately following the

first injection, a second 1 ml subcutaneous injection

of Lilly U-40

IletirfiD regular insulin (Eli Lilly and Co., Indianapolis, Indiana) di-·
luted to one of several concentrations with isotonic pyrogen-free saline
was given in the subscapular region.

Preparation of insulin solutions

was done with non-glass labware to avoid losses due to non-specific
binding.

Dilutions ranging from 0.5 Ujml to 1.5 Ujml were utilized.

The rats were then weighed, marked for identification and returned to
their cages with only tap water provided.

The number of hypoglycemic

convulsive deaths which occured in the 24 hours after injection were
tabulated.

Significance of the difference in lethality between groups

was assessed by the chi square test with Yates correction factor run on
a PDP-12 Digital Computer (Digital Equipment Co., Maynard, Massachusetts).

A "p" value less than 0.05 for chi square (104) was considered

statistically significant.
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E.

Intravenous Glucose To 1erance Testing_
Fasted rats were given either 5 mg PbAc or 5 mg NaAc 4 hours

before the tolerance test.

At t

=

-15 minutes, the animals were anes-

thetized ~ith 32.5 mg/kg Pentobarbital Sodium (Holmes Serum Co., Inc.,
Springfield, Illinois) administered as a 1 ml ip injection of a fresh
pre-diluted solution of the 65 mg/ml sodium pentobarbital in isotonic
nonpyrogenic saline.

The level of anesthesia. was considered adequatev1h:n

the ta i1 was 1 ir.~p and breathing was regular.

Contra 1 ( C;) and succeed-

ing blood samples were taken from a tail snip.

Using a sharp pair of

scissors, just the tio of the tail was cut off and then the tail was
milked to promote blood flow.
~1

Samples were collected directly into 250

heparinized, fluoride-treated microfuge tubes (Beckman).

At time

zero, after the control sampling, 200 mg of 0-glucose (Sigma Laboratories, St. Louis, Missouri) as 1 ml of 20% glucose in isotonic saline
was administered iv.

The glucose solution was prepared the night before

to allow for mutarotation and kept refrigerated.

Subsequent blood

samples of about 0.2 ml were taken at 5 minute intervals from 5-45
minutes.

After the last sample, the blood was rapidly separated into

plasma and cells in a Beckman Microfuge Model 152 and then frozen at

ooc

until glucose analysis.
Plasma glucose concentrations v1ere determined using the
Yellow Springs Glucose Analyzer
Yellow Springs, Ohio).

(Vella~

t~ode 1

23l\

Springs Instrument Co., Inc.,

This instrument measures glucose concentration

in a 25 Jll sample by the amount of hydrogen peroxide produced in the
glucose oxidase reaction (367). After thawing on ice and mixing of the
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plasma layer, samples were done in triplicate except when the first 2
readings differed by 2 mg/dl or less and then the mean calculated for
each sample.

To check for linearity of response, the analyzer was

standardi?ed with 200 and 500 mg/dl glucose solutions (Yellow Springs).
In order to analyze the data, the log 10 of the plasma glucose
concentrations was plotted against time in minutes for each rat. Then
the best straight line through the 5-30 minute points was drawn and
extrapolated to the ordinate so that the theoretical concentration at
time zero (C 0 ) could be determined.

The time at which the glucose con-

centration was one half of the C0 was considered the half-time

(t~)

glucose disappearance from the vascular compartment (298, 360).

of

The k

value or % glucose disappearance/min can be obtained by the formula
k=

0.693/t~

x 100%, since during the initial 30 min measured,the

change in plasma glucose with time appeared to be a single exponential
function.
lated for

The mean, standard deviation and standard error were calcu-

c.,
1

C and
0

t~.

The significance of the difference between

the means was determined using Student's unpaired "t'' test with p

<

0.05

considered statistically significant done on the PDP-12 computer.
F.

Determination of Basal and Glucose-Stimulated Serum Insulin Levels

in RES Depressed Rats
Both basal and glucose-stimulated serum immunoreactive insulin
levels (IRI) were measured in rats at various times after administration
of an RES depressant and in controls.

Sodium pentobarbital at a dose of

32.5 or 43.3 mg/kg as a 1 ml ip injection of a freshly prepared dilution
in isotonic nonpyrogenic saline was used.

For basal samples, a cardiac
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puncture of at least 1-3 ml was taken with a 5 ml syringe with a 20
gauge needle at 15 min after induction of anesthesia or time zero.
Glucose-stimulated serum samples were obtained 5 min after a 1 ml iv
injection of 400 mg of D-glucose (Sigma) at time zero as 40% glucose in
isotonic saline prepared the previous night and refrigerated.

It has

been shown that the peak insulin response to a glucose pulse occurs
between 2-5 min following the stimulus (39, 267, 289) and 5 min also
allowed for adequate mixing in the vascular compartment.

After the

cardiac puncture, the needle was removed from the syringe and blood was
carefully transferred to glass tubes on ice to prevent hemolysis and
allowed to clot.

Clots were rung and the samples centrifuged, the serum

removed and frozen at

ooc

in plastic vials.

Serum glucose was measured

using the YSI Glucose Analyzer as described previously.

Serum IRI was

determined on 4 replicates of the serum samples using the Phadebas Insulin Test radioimmunoassay (RIA) kit (Pharmacia Laboratories, Inc.,
Diagnostics, Piscataway, New Jersey) as described below.
compared using Student's unpaired

11

t 11 test with p

<

Data \'Jere

0.05 as the level

of statistical significance.
Serum samples were taken at 4 hours after 5 mg PbAc iv in overnight
fasted rats because the RES is depressed (143) and metabolic changes
have been noted at 4-6 hours after lead (140).

For the carbon blockade

studies 3 time points were chosen for measurement of basal serum glucose
and insulin.

Fasted rats were subjected to either a 4 or 8 carbon

blockade since there is decreased RES function at 4-8 hours (12, 22,

14~

144, 152, 205, 213, 259, 301) and altered glucoregulation has been
reported (144).

An 18 hour carbon blockade was also used with a slight
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difference in protocol in that rats were injected with carbonorvehicle
and then fasted overnight for a total of 18 hours since both carbon and
lead treatment before an overnight fast resulted in depressed hepatic
gluconeogenesis (84, 144) and a trend

toward recovery of phagocytic

function after carbon blockad has been demonstrated within one day
(22, 38, 103, 205).
G.

Immunoreactive Insulin Assay
The Phadebas Insulin Test RIA kit (Pharmacia) vJas used to assay

serum insulin (IRI) levels in rat serum samples.

This RIA utilizes

guinea pig anti-porcine insulin antibodies covalently bound to Sephadex
particles as the solid phase which has several advantages such as ease
of separation of bound and unbound insulin, high stability, high antigen
binding capacity and little tendency for non-specific adsorption of
proteins and polypeptides (356, 357).

The concentration of insulin in

an unknovm sample was evaluated by its capacity to compete with a fixed
amount of labeled I-125 insulin for insulin antibody binding sites compared to known concentration insulin standards.

Since rat insulin is

not readily available, a porcine insulin standard was used as a relative
reference.
Seven insulin standards of 3.2, 8, 16, 32, 80, 160 and 320
were prepared by both single and serial dilution steps (261).
time of assay, serum was thawed and 250
mixed with 250

~1

~1

~U/ml

At the

of each well-mixed sample was

of the RIA kit buffer solution resulting in 500

~1

half-dilutions of the samples which was done for the following reasons:
1) only a

s~all

quantity of serum was required for assay, 2) samples

with high insulin levels were assayed at a more readable portion of the

44
standard curve and 3) dilution of high insulin samples made dilution of
all samples obligatory because IRI measured by RIA is augmented by dilution (284).

Four 100

~1

replicates of each sample were assayed follow-

ing the manufacturer's procedure (261).

Each time the RIA was done,

triplicates of the buffer and duplicates of the standards, Pharmacia
human

refe~ence

serum and pooled fed rat serum were run preceding and

following the unknowns to check the reproducibility of the RIA.
coefficient of variation for samples was

~

15%.

The

Detailed information on

the precision and accuracy of this RIA method is available (51, 341).
Oxford Samplers (Oxford Laboratories, Inc., Foster City, California)
were used for pipetting except for the Sephadex anti-insulin complex
which was pipetted with a 1 ml Cornwall Syringe (Type BD, Becton, Dickinson, Rutherford, New Jersey) specially adapted with narrow polyethylene tubing to prevent sedimentation.

Assay mixtures containing

1~125

insulin, sample and sephadex antibody complex in buffer were incubated
24-36 hours in Pharmacia plastic 12 x 55 mm stoppered RIA tubes at room
temperature on a horizontal RIA Shaker (Pharmacia).

Incubation was

terminated by centrifugation for 2 min in a 96 position IEC swinging
bucket head at 1,500 x gin an IEC Model PR-J refrigerated centrifuge.
After the stoppers were removed, the centrifugation was repeated at
1,500 x g for 4 min,after which an adjustable collared pipette coupled
to a water vacuum pump was used to aspirate the supernatant to approximately 5 mm from the bottom of the tubes.

Three washes of the Sephadex

particles were done with 2 ml of pH 7.0-7.5 isotonic saline kept on ice
using a 5 ml Cornwall syringe followed by a 4 min centrifugation.

The

tubes containing the sediment were gently placed into uncapped 16 x 25
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mm polystyrene gamma counting vials (Amersham Corp., Arlington Heights,
Illinois) and counted for 10 or 20 min in a Searle/Analytic Model 1185
Gamma Counter (Amersham/Searle, Arlington Heights, Illinois).
In order to calculate the sample insulin concentrations, the mean
count rate for each of the standards in cpm minus background was
expressed as a percentage of the background corrected count rate of the
zero samples which contained only buffer plus Sephadex antibody complex
and I-125 insulin.

A linear transform of the plot of the percent acti-

vity bound versus the log 10 of the insulin concentration was calculated
with a regression program run on the computer. Another program calculated the mean insulin concentration, standard deviation, standard
error and coefficient of variation for each sample (51).

The resulting

concentrations were multiplied by 2 to correct for dilution of the
samples.

RESULTS
Insulin Induced Hypoglycemic Lethality with Acute Lead Administration
A series of experiments was done to determine whether RES depression by atute lead acetate administration would affect the incidence of
insulin-induced lethal hypoglycemia.
l and table 1.

These data are displayed in figure

Figure 1 shows that 5 mg lead acetate (PbAc) iv elevated

the incidence of lethal hypoglycemic convulsions at the 4 insulin dosages used.

Both figure 1 and table indicate that the lower doses of in-

sulin, 0.5 and 0.75 U, though not lethal to saline controls did cause
some deaths in lead-treated animals.

However, statistically significant

enhancement of lethality occurred with 1.0 U insulin (70%) and 1.5 U insulin (95%) with lead administration.

Comparison of the overall %

lethality in the saline and lead-treated groups regardless of the insulin dosage also reveals an increased sensitivity to insulin-induced
hypoglycemic death.

Lead acetate given alone is non-lethal at a dose of

5 mg/300 g rat (135).
Intravenous Glucose Tolerance After Acute Lead Administration
In order to further evaluate the altered insulin sensitivity accompanying acute lead administration, iv glucose tolerance testing was done
4 hours after 5 mg of lead acetate (PbAc) or sodium acetate (NaAc), using
200 mg of glucose.

Figure 2 demonstrates a 50% reduction in half-time

(T12 ) of glucose disappearance, i.e. increased glucose tolerance in the
lead treated rats.

The basal or initial plasma glucose levels (Ci) of

the 2 experimental groups \vere not significantly different (table 2). The
46
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TABLE l
INSULIN HYPOGLYCEMIC LETHALITY WITH
ACUTE LEAD ADMINISTRATIONa
Experimental
Group

Number
of Rats

Control, 0.9% Saline

Insulin Dose
(Units/Rat) Lethality

20

0.50

0%

10

0.75

0%

20

1.00

5.0%

20

l. 50

40.0%

70b
Lead Acetate, 5 mg

12.8%

30

0.50

16 7%

10

0.75

30.0%

30

1.00

70.0%c

20

l. 50

95.0%c

90b

0

53.3%c

a Overnight fasted rats received a l ml iv injection of
either 5 mg/ml lead acetate or 0.9% saline immediately
followed by a l ml injection of insulin sc.

Lethality

was recorded at 24 hours.
b Total lethality of all rats in the experimental group
regardless of insulin dose.
c

p<O.OOl as compared to control groups using the Chi

Square test with Yates correction factor.
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FIGURE 1
EFFECT OF ACUTE LEAD ADMINISTRATION ON
INSULIN HYPOGLYCEMIC LETHALITY
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Overnight fasted rats received a 1 ml iv injection of either 5 mg
lead acetate or 0.9% saline immediately follov1ed by a 1 ml insulin injection sc of one of 4 dosage levels.
N = the number of rats in the group.

Lethality was recorded at 24 hours.
The 2 bars on the far right show %

lethality of all rats in the experimental group regardless of insulin dose
(all doses).

Statistical significance of the data was evaluated using

the Chi Square test with Yates correction factor.

N.S.

=

not significant.
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TABLE 2
GLUCOSE TOLERANCE (200 mg iv) AFTER ACUTE LEAD ADMINISTRATIONa
Experimt::ntal
Group·

Plasma Glugose Plasma Glucose
Number Basal (C;)
At Time Zero
of Rats (mg/dl)
(C 0 )C (ng/dl)

---------------

Half-Time (TO;;)
Glucose Disappearance (min)

----------------------------

Control,
Sodium Acetate
5 mg

10

Lead Acetate
5 mg

10

75 + 4

P-Va 1uee

N.S.

305 + 10

49 + 6

359 + 21

24

0.032

<0.001

+ 3

a Overnight fasted rats received a 1 ml iv injection of either lead
acetate or sodium acetate (5 mg/ml) 4 hours before iv glucose
tolerance testing.
b Plasma glucose immediately before injection of 200 mg glucose iv

at 0 min.
c Value of plasma glucose at time= 0 min obtained by extrapolation of
the line -- 10910 plasma glucose vs. time -- to 0 min.
d f1ean

+

standard error.

e Group data were compared using the unpaired Student 1 S "t" test.
P

=

<0.05 was considered statistically significant.

fi cant.

N.S. = not signi-
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FIGURE 2
EFFECT OF ACUTE LEAD AmHNISTRATION ON THE
HALF-TIME OF GLUCOSE DISAPPEARANCE
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Overnight fasted rats received a 1 ml iv injection of either 5 mg
lead acetate or sodium acetate 4 hours before iv glucose tolerance testing.

c.1

is the mean basal plasma glucose of the experimental groups

immediately before iv injection of 200 mg glucose at 0 min.

Note that

the lines are not drawn through the mean plasma glucose concentration at
each time point but were drawn utilizing the mean theoretical plasma
glucose concentration at time zero (C 0 ) and the mean half-time of glucose disappearance (T~) of the 10 rats in each group.
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group mean C0 , the glucose level at time zero, was significantly higher
in the PbAc group compared to the NaAc group (table 2).
Basal and

~ucose-Stimulated

Serum Glucose and Insulin Levels 4 Hours

After Acute Lead Administration
Since the preceding experiments suggested a role for the RES in
modulating insulin activity, actual measurements of serum glucose and
insulin (IRI) levels were done both in the basal fasting state and 5 min
after 400 mg glucose iv.

As shown in table 3 and figure 3, RES depression

by administration of PbAc 4 hours prior raised basal serum insulin levels
(p = 0.018) although serum glucose was unchanged, resulting in the elevation of the I/G (insulin to glucose) ratio.

At 5 min after 400 mg glucose

iv (table 4 and figure 4), there was a 6-fold increment in serum insulin
levels (p

<

0.001).

Though serum glucose was higher in the PbAc group,

the I/G ratio still showed a 6-fold increase compared to that for NaAc
controls.

This suggests an exaggerated insulin response to the prevailing

glucose levels.
Basal and Glucose-Stimulated Serum Glucose and Insulin Levels After
Colloidal Carbon Blockade
Further investigation of the effect of altered RES function on insulin regulation was carried out using inert non-toxic colloidal carbon

(~8~

to induce a state of blockade or decreased phagocytic function (36).

At

4 hours after injection of 32 mg/100 g of colloidal carbon, there was a
decrease in basal serum glucose levels compared to the uninjected controls,
(p

=

0.016) but not the sham vehicle controls (table 5).

The 4 hr carbon
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TABLE 3
SERUM GLUCOSE AND INSULIN LEVELS 4 HOURS AFTER ACUTE LEAD ADMINISTRATIONa
Experimenta.l
Group

Number
of Rats

Serum
Glucose
(mg/dl)

Serum IRI b
(f.IU/ml)

I/Gc

Control,
Sodium Acetate
5 mg

8

116 + 2d

9.4 + 0.5

0.082 + 0.005

Lead Acetate 5 mg

8

110 + 3

15.2 + 2.1

0.139 + 0.022

N.S.

0.018

0.024

P-Value e

a A l ml iv injection of 5 mg/ml lead acetate or sodium acetate was
administered to fasted rats 4 hours before blood sampling.
b Immunoreactive insulin (IRI) was measured by the Phadebas method.
c Ratio of the serum IRI in f.IU/ml to serum glucose in mg/dl.
d Mean + standard error.
e Group data were compared using the unpaired Student•s
P

<

0.05 was considered statistically significant.

ficant.

N.S.

11

t" test.

= not signi-
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FIGURE 3
EFFECT OF ACUTE LEAD ADMINISTRATION ON
SERUM GLUCOSE AND INSULIN LEVELS
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I
GLUCOSE

INSULIN
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8
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.082±.005

.139±.022

A l ml iv injection of either 5 mg lead acetate or sodium acetate
was administered to fasted rats 4 hours before blood sampling.

Basal

serum glucose and insulin (IRI) levels are shown.

I/G is the ratio of

the serum IRI in

N = number of rats

per group.

~U/ml

to serum glucose in mg/dl.
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TABLE 4
EFFECT OF ACUTE LEAD ADMINISTRATIONa ON SERUr·1 GLUCOSE
AND INSULIN LEVELS 5 MIN AFTER 400 mg GLUCOSE iv
·•

Experimental
Group

Number
of rats

Control~

Serum
Glucose
(mg/dl)

Serum IRib
(llU/ml)

34.6 + 4.7

Sodium Acetate
5 mg

8

569 + gd

Lead Acetate
5 mg

8

652 + 27
0.011

P-value

I/Gc

0.062 + 0.009

235.5 + 17.4 0.362 + 0.024
<

0. 001

<

0. 001

a A 1 ml iv injection of 5 mg/ml lead acetate or sodium acetate was
administered to fasted rats 4 hours before the time of glucose injection.
b

Blood samples were taken at 5 min after 400 mg glucose iv.

Immunoreactive insulin (IRI) was measured by the Phadebas method.

c Ratio of the serum IRI in llU/ml to serum glucose in mg/dl.
d Mean + standard error.
e Group data were compared using the unpaired Student's "t" test.
P

<

0.05 was considered statistically significant.
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FIGURE 4
EFFECT OF ACUTE LEAD ADMINISTRATION ON SERUM
INSULIN LEVELS 5 MIN AFTER GLUCOSE [400 mg iv]
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A 1 ml iv injection of either 5 mg lead acetate or sodium acetate
was administered to fasted rats 4 hours before the time of glucose injection.

Blood samples were taken 5 min after 400 mg glucose iv.

insulin (IRI) levels and the ratios (I/G) of the serum IRI
serum glucose (mg/dl) are depicted.

Serum

(~U/ml)

N =number of rats per group.

to
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TABLE 5
SERUM GLUCOSE AND INSULIN LEVELS AFTER
COLLOIDAL CARBON BLOCKADEa
Experimental
Group
A)

B)

C)

Serum
Glucose
(mg/dl)

Serum IRI b
(JlU/rnl)

I/Gc

Uninjected Control
l) 4- hr prior
87 + 4 (8)d
2) 8 hr prior 103 + 4 ( 15)
3) 18 hr prior
68 + 3 (6)

32.4 + 4.0 ( 8)
20.9 + 1.5 ( 14)
26.8 + 2.6 (4)

0.385 + 0.064 (8)
0.213 + 0.019 ( 14)
0.384 + 0.033 (4)

Sham Vehicle Control
1 ) 4 hr prior
80 + 5 (8)
2) 8 hr prior 106 + 4 ( 14)
3) 13 hr prior
77 + 2 ( 16)

20.9 + 2.9 (8)
20.7 + 2.0 ( 15)
27.0 + 2.3 (6)

0.277 + 0.049 (8)
0.193 + 0.021 ( 14)
0.350 + 0.028 (6)

Carbon Blockade
1 ) 4 hr prior
2) 8 hr prior
3) 18 hr prior

65 + 7 (8)
108 + 4 ( 17)
67 + 3 (8)

0.460
29.8 + 0.8 (7)
39.8 + 2.8 (17) 0.37!3
0.427
27.9 + 2.7 (8)
----a Overnight fasted rats received 32 mg/100 g of colloidal

+ 0.048 (7)

-

+ 0.033 ( 17)
+ 0.050 (8)

carbon (3 ml

of 32 mg/ml) or equivalent volume of vehicle iv or no treatment either
4 or 8 hr prior to blood sampling.

For 18 hr blockade, fed rats were

injected and then fasted 18 hr prior to blood sampling.
b Immunoreactive insulin (IRI) was measured by the Phadebas method.
c Ratio of the serum IRI in JlU/ml to serum glucose in mg/dl.
d Mean+ standard error (number of animals).
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TABLE 5 (cont.)
SERUM GLUCOSE AND INSULIN LEVELS AFTER
COLLOIDAL CARBON BLOCKADEa
Critical
Compan. sons e
Serum Glucose

Serum Insulin

I/G

P-values

A-1 vs. C-l

0.016

A-3 vs. B-3

0.032

B-3 vs. C-3

0.016

A-1 vs. 8-l

0.035

B-1

0.011

VS.

C-1

A-2 vs. C-2

<

0. 001

8-2 vs. C-2

<

0. 001

B-1 vs. C-1
A-2

0.019

C-2

<

0. 001

B-2 vs. C-2

<

0. 001

VS.

e Group data were compared using the unpaired
Student's "t" test.

Only statistically

significant comparisons with p-value
are given.

<

0.05
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rats also showed an elevation in basal serum insulin (p

=

0.011) in

comparison to the sham vehicle controls resulting in an elevated I/G ratio
(figure 5, table 5).

But uninjected control basal serum insulin levels

were higher than those of the sham vehicle group (p

=

0.035) and not

statistically different from those of the carbon-treated rats (table 5,
figure 5).

In contrast to the 4 hr carbon blockade study, 8 hr carbon

blockade resulted in a highly significant doubling of basal serum insulin
concentration compared to both control groups (p

<

0.001) although the

serum glucose concentration remained the same in all 3 groups (table 5,
figures 5 and 6) resulting in a doubling of the I/G ratio.

Table 6 and

figure 7 display the effect of an iv 400 mg glucose stimulus on serum
insulin levels 5 min after injection in the 8 hr carbon blockade group.
An even more exaggerated 3-fold serum insulin increase occurred compared
to both sham vehicle and uninjected controls {p

<

0.001).

Serum glucose

levels were similar in all 3 groups, however, resulting in a corresponding
rise in the I/G ratio (table 6, figure 7) in the 8 hr carbon blockade
animals after glucose.

In the fed rats which received carbon and were

then fasted 18 hr (18 hr carbon blockade), basal serum glucose, insulin
and the I/G ratios were not significantly different from the controls as
seen in figure 5 and table 5.
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FIGURE 5
EFFECT OF ALTERED RES FUNCTION
ON SERUM INSULIN LEVELS

I

'i
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UNINJECTED
CONTROLS
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~
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CARBON:

0
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Overnight fasted rats received colloidal carbon (32 mg/100 g) iv,
an equivalent volume of vehicle iv or no treatment either 4 or 8 hours
prior to blood sampling.

For the 18 hour group, fed rats were injected

and then fasted 18 hours prior to blood sampling.

(IRI) levels are depicted.
group.

Basal serum insulin

N = number of rats yielding samples in each
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FIGURE 6
EFFECT OF CARBON BLOCKADE ON SERUM
GLUCOSE AND INSULIN LEVELS

50

INSULIN
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0
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±.019

1415

o

1717

SHAM
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BLOCKADE {8HRS PRIOR)

.193±.021

.378±.033

Data from the 8 hr colloidal carbon injected (carbon blockade),
sham vehicle controls (sham blockade) and uninjected controls (Figure 5
and Table 5) are shown in detail.
are depicted.
cose in mg/dl.

Serum glucose and insulin (IRI) levels

I/G is the ratio of the serum IRI in vU/ml to serum gluN =number of rats yielding samples in each group.
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TABLE 6
EFFECT OF 8 HOUR CARBON BLOCKADEa ON SERUM GLUCOSE AND
INSULIN LEVELS 5 MIN AFTER 400 mg GLUCOSE iv

Serum
Glucose
(mg/d1)

Experimental
Group

Serum !Rib
(llU/n1)

I/Gc

Uninjected control

544 + 21 ( 16) d

38.2 + 2.2 ( 14)

0.077 + 0.005 ( 14)

Sham Vehicle
Control

531 + 17 ( 17)

34.6 + 2.1 ( 17)

0.065 + 0.004 (17)

Carbon Blockade

539 + 28 ( 17)

116.6 + 9.7 (l7)e 0.226 + 0.022 {17)e

a Overnight fasted rats received 32 mg/100 g of colloidal carbon (3 ml
of 32 mg/ml) or equivalent volume of vehicle iv or no treatment 8 hr
before the time of glucose injection.

Blood samples were taken at 5 min

after 400 mg glucose iv.
b Immunoreactive insulin (IRI) vJas measured by the Phadebas method.
c Ratio of the serum IRI in

llU/ml to serum glucose in mg/dl.

d Mean + standard error (number of animals).
e P

<

0.001 as compared to either the uninjected control or sham vehicle

control groups using the unpaired Student s
1

statistically significant.

11

t

11

test.

P

<

0.05 considered
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FIGURE 7
EFFECT OF CARBON BLOCKADE ON SERUM INSULIN
LEVELS 5 MIN AFTER GLUCOSE [400 mg iv]

.25
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li
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75
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.10
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GROUP: CONTROL
SERUM
GLUCOSE= 544±21
[mg/diJ

17

17

SHAM
CARBON
BLOCKADE (8 HRS PRIOR)

531±17

539±28

Overnight fasted rats received colloidal carbon (32 mg/100 g -carbon blockade) iv, an equivalent volume of vehicle (sham blockade) iv
or no treatment 8 hr before the time of glucose injection.
were taken 5 min after 400 mg glucose iv.

Blood samples

Serum insulin (IRI) levels and

the ratios (1/G) of the serum IRI (vU/ml) to serum glucose (mg/dl) are
depicted.
group.

N =number of rats yielding serum insulin samples in each

DISCUSSION
Effect of Acute Lead Administration on

Insuli~oglycemic

Lethality_.

The toxic effects of lead were recognized since antiquity and descriptions of acute lead poisoning date back to Hippocrates and Nicander
(69, 182).

Starting from the seventeenth century the more subtle as-

pects of lead poisoning have been investigated, especially because lead
is an ubiquitous environmental contaminant which primarily affects children with pica causing a constellation of hematological, neuromuscular,
gastrointestinal and central nervous system disorders (69, 182, 234).
One of the more ominous of the reported consequences of lead ingestion
in man is a fatal shock episode (182).
Selye et

~.,while

investigating the pharmacological actions of

heavy metals observed that iv administration of a non-lethal 5 rng quantity of lead acetate to rats resulted in a 100,000-fold increase in
endotoxin susceptibility (288).

The lead enhancement of endotoxin shock

lethality was maximal when both agents were administered sin1ultaneously
(80, 288).

Filkins and Buchanan utilized this synergism to develop an

endotoxin bioassay (53, 135, 143).

Selye's hypothesis for the lead

effect was that it produced a blockade of the RES (288).

Subsequent

studies substantiated that hypothesis since a non-lethal dose of lead
acetate--5 mg/300 g rat--did depress the RES clearance of colloidal carbon (143) and l31I-labeled lipid emulsion (330).

Kupffer cell phago-

sornes containing electron-dense material (lead?) have been identified in
both hepatic and splenic macrophages along with later hepatic ultra63
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structural changes (80, 190) after lead administration.

It has also

been reported that parenterally administered lead salts attached primarily to erythrocyte membranes with the remainder r.apidly precipitating
to form colloidal particles which vJere distributed in the 1 iver, spleen
and bone marrow (84).
The mechanism of the lead sensitization to endotoxin remained a
mystery.

The degenerative morphological changes noted in hepatic Kupf-

fer and parenchymal cells did not correlate with the time response of
lead-induced endotoxin hypersensitivity (80, 190).

Furthermore, Filkins

and Buchanan demonstrated that lead administration altered neither the
~vivo

vascular clearance nor the in vitro hepatic detoxification of

endotoxin (143).

These investigators interpreted the data as indicating

that a 11 metabolic lesion 11 was the basis of lead's action (143).
The combination of lead and endotoxin produced hypoglycemia, glycogen depletion and depression of gluconeogenesis in baboons (80), mice
(272) and rats (140) all characteristic of endotoxin shock (26, 52, 54,
55, 56, 79, 87, 134, 140, 145, 146, 172, 188,.189, 225,263,272, 290,-291'
292, 303, 363, 364).

Further experimentation revealed that lead acetate

alone depressed gluconeogenesis from lactate, pyruvate and alanine both
1!:!_ vivo and iQ_ vitro using isolated hepatocytes (84, 140).

produced glycogen depletion (140, 272).

Lead also

In vitro addition of lead ace-

tate to isolated hepatocytes had no effect on gluconeogenesis (84),
suggesting that the lead-induced alterations in glucose metabolism must
be mediated by another substance.
With the knowledge that insulin is the dominant physiologic regulator of carbohydrate metabolism (97, 132), a lethality study was done to
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determine whether the metabolic changes noted after RES depression by
'

lead acetate might be due to alterations in insulin responsivity
regulation.

or

A series of lethality experiments was done to evaluate the

susceptibility to insulin-induced hypoglycemic convulsive death in leadtreated rats versus saline controls.

Four different dosages of insulin

were utilized randomly in the 2 groups of fasted rats.

As depicted in

both table 1 and figure 1, at every dose level, insulin administration
resulted in hypoglycemic convulsions followed by death in a portion of
the lead-treated rats.

In comparison, note that both the 0.5 and 0.75 U

doses of insulin were non-lethal in the saline treated control animals.
Statistically significant elevations in lethality did occur with lead
treatment at the higher dosages of 1.0 and 1.5 U of insulin.

Comparison

of the results in the 2 experimental groups regardless of insulin dose
also revealed an increase in lethality in the lead acetate group.

All

deaths occurred 4 to 12 hours following insulin injection and were preceded by the signs and symptoms of hypoglycemia i.e. loss of consciousness, convulsive spasms and coma (124).
These results confirmed and expanded upon an earlier study by
Buchanan and Filkins, in which leat-treated rats displayed increased
sensitivity to one dose level of exogenous insulin and to endogenous insulin release induced by tolazamide as manifested by an elevation of the
incidence of lethal hypoglycemia (52).

Recently Filkins demonstrated

that RES depression by colloidal carbon blockade markedly enhanced sensitivity to lethal insulin hypoglycemia in rats (142, 144).

Since acute

endotoxin administration produces an RES depressed state (20, 23, 179,
192, 323), the reports of Pieroni and Levine (263) and Buchanan and
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Filkins (55) that endotoxin shock lethality was increased by administration of insulin or beta cell stimulants provide additional support
for the notion that RES depression results in altered responsivity to
insulin.

Shands et

~-

also reported endotoxin-induced insulin sensi-

tivity in mice; however, their results are difficult to interpret
because the mice were infected with Mycobacterium bovis BCG prior to the
experiment (292).

Although insulin tolerance testing in rats given the

RES depressants colloidal carbon (142), lead (52) or endotoxin (142)
demonstrated an enhanced hypoglycemic response to exogenous insulin as
shown by blood or plasma glucose measurements, the mechanism of this
insulin sensitization remained unexplained.
One potential explanation for this phenomenon is an alteration of
tissue responsiveness to insulin.
ed in depth.

This possibility has not been explor-

A second explanation could be a failure or diminished

effect of insulin counter-regulatory systems such as glucagon, growth
hormone, corticosteroids and the sympathetic nervous system (97, 124).
Glucagon insufficiency has been proposed as a cause for hypoglycemia
but it is a rare occurrence (124).

The role of glucagon in glucose

regulation has recently been minimized since glucagon has an evanescent
effect on hepatic glucose production and no known effect on peripheral
glucose disposal (68, 132).

Sacca et

~l·

reported that even though

glucagon was involved in the metabolic reaction to insulin-induced hypoglycemia in the rat, its role was not essential because rats rendered
glucagon-deficient tended to recover normally (281).

Growth hormone is

normally released during hypoglycemia (97) and a deficit in its secretion has been demonstrated only in ateliotic dwarfs (124).

A deficiency
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in glucocorticoids can exacerbate or even casue hypoglycemia but adrenal
or pituitary hypofunction would have to be demonstrated (124).

Finally

the activity of the sympathetic nervous system normally is increased in
a stressful state such as hypoglycemia (97) and its dysfunction is more
likely the result of rather than the cause of a hypoglycemic reaction
(124).

A third possibility for the sensitization to insulin manifested

after RES depression could be the production of additional non-suppressible insulin-like activity or NSILA; however, Eigenmann and associates
reported that NSILA levels did not change following manipulations of
blood sugar in the dog and they concluded that in physiological terms
NSILA appears to be only an insulin-like growth factor (114).

The

fourth and most obvious explanation for the increased insulin lethality
with decreased RES function is a defect in insulin regulation.

The hypo-

glycemia resulting from the insulin increase in the animal would suppress
pancreatic insulin secretion (97, 124) pointing to a potential defect in
insulin removal or degradation.

A decrease in insulin extraction by the

key insulin degrading organs, especiallv the liver (133), could promote an
elevation of circulating insulin in the RES

d~~ressed

demonstrated in the obese-hyperglycemic mouse (207).

animal as has been
Before the advent

of modern radioimmunoassay methods, insulin was assayed by noting the
incidence of severe hypoglycemic reactions in mice (368), lending further support to the notion of a defect in insulin extraction and catabolism in the RES depressed state.
Intravenous Glucose Tolerance After Acute Lead Administration.
In order to further evaluate the altered insulin status accompany-
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ing RES depression, iv glucose tolerance was measured in rats 4 hours
after either lead acetate or sodium acetate treatment.

As displayed in

table 2 and figure 2, the lead-treated group demonstrated an increase
in glucose tolerance with a reduction of the half-time of glucose disappearance from 49 min in the sodium control group to 24 min in the
lead group.

The basal fasting plasma glucose values in the two groups

were not significantly different (table 2) and were in the appropriate
range for fasting (360), indicating that the rats were in a normoglycemic state immediately before tolerance testing.
The iv glucose tolerance test was used because, even though it is
a relatively non-specific test, the results are readily interpreted and
the decrease in plasma glucose is significantly influenced by the effect
of insulin on hepatic glucose production and peripheral tissue glucose
uptake (132, 298, 360).

Therefore, changes in glucose tolerance can be

directly related to insulin activity and barring any evidence of insulin
resistance, to the insulin levels present after the glucose stimulus
(298).

Normally an iv infusion of glucose results in two phases of pan-

creatic insulin secretion, a rapid phase beginning 1 min after the start
of the infusion and lasting about 3 to 5 min followed by a slower phase
beginning approximately 10 min after the start of the infusion (39, 267,
289).

Stress is a significant cause of glucose intolerance and there-

fore false tolerance test results (360, 365).

Increased sympathetic

activity and catecholamine release have been shown to cause inhibition
of pancreatic insulin output, retardation of glucose utilization and
accelerated appearance of endogenous glucose (289, 295, 365).

In order

to eliminate this variable, the rats were anesthetized with sodium
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pentobarbital, allowing a 15 min waiting period before the start of the
test to insure that they were fully relaxed and asleep with a regular
breathing pattern.

The dose of glucose used was 200 mg/300 g or 0.666

g/kg which is within the accepted range of glucose dosages used for
glucose tolerance testing (56, 87, 144, 295, 360).
In this study, RES depression by acute lead treatment increased
glucose tolerance as shown by a 50% reduction in the half-time of
glucose disappearance from the vascular compartment.

This data agreed

with the results of another study by Filkins and Buchanan in which they
demonstrated that decreasing RES function by colloidal carbon blockade
caused a 3-fold reduction in the glucose disappearance half-time (145).
Thus in 2 different models of RES depression there was physiological
evidence of an increase in insulin activity.

In interpreting these

data, it should be considered that there is no evidence at present for
an altered response to insulin at the tissue level with RES depression
alone.

It is probable that the increased glucose tolerance resulted

from elevated circulating insulin levels.
Several other alterations in glucose metabolism that hint of a
functional hyperinsulinemic state have been reported with reduced RES
function.

Depression of hepatic gluconeogenesis was observed after

acute lead administration (84, 140), colloidal carbon blockade (144)
and endotoxin administration (56, 145, 146, 188, 225, 291 ).

The

occurrence of increased disappearance or utilization of glucose in
endotoxin shock is well known (56, 188, 363).

Measurements of in vivo

whole body glucose oxidation after lead (Filkins, unpublished results),
carbon blockade (144) and endotoxin (56, 134) demonstrated increased
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insulin activity at the tissue level.

The endotoxin-induced hypercata-

bolism of glucose could be eliminated by the use of dexamethasone (134)
or by rendering the rats insulinopenic by either mannoheptulose or
streptozotocin treatment (56).

Hypercatabolism of glucose by various

tissues taken from endotoxic rats was also diminished by anti-insulin
agents (134).

The combination of decreased gluconeogenesis and increas-

ed glucose utilization in endotoxemia ultimately results in hypoglycemia
(26, 55, 56, 134, 145, 146, 172, 188, 189, 290,303,

36~.

Buchanan, in his

investigation of the metabolic alterations of endotoxemia in the rat,
performed ip glucose tolerance tests with insulin measurements in groups
of rats; he noted no alterations of glucose tolerance despite an exaggerated insulin response (56).

Endotoxic rats receiving ialine also

displayed an elevation of serum insulin levels (56), strengthening the
notion that RES depression may foster a hyperinsulinemic state.
Basal and Glucose-Stimulated Serum Glucose and Insulin Levels After RES
Depression.
With the knowledge that both hyperinsulinemia and hypoglycemia were
present in the endotoxin-treated rat (56) and since acute endotoxin administration causes RES depression (20, 23, 179, 192, 323), which is
characterized by altered glucose regulation suggestive of a hyperinsulinemic state (table 2) (56, 84, 134, 140, 144, 145, 146, 188, 225, 291,
363), it seemed logical to investigate the effect of RES depression on
serum glucose and insulin levels.
investigated:

Two models of RES depression were

acute lead treatment and colloidal carbon blockade.

These models were utilized because of the previous data on altered glucoregulation and because they are non-lethal (135, 180) in comparison to
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endotoxin which can cause a fatal shock episode.

The effect of

colloidal carbon would be especially significant since this is a

classi~

inert, non-toxic RES test and blockade substance (20, 21, 36, 179, 180,
309) which should not produce any deleterious effects in addition to RES
depression.

In contrast, acute treatment of 300 g rats with 5 mg lead

acetate, though non-lethal (135), might have some toxic effects since
heavy metals can combine with sulfhydryl and other groups to inhibit
various enzyme systems and perhaps altering membrane permeability {182,
333).

Both serum glucose and insulin were measured in the basal fasting

state and 5 min after 400 mg of glucose iv, which allowed for adequate
mixing and equilibration time in the vascular compartment, and should
reflect the rapid phase of pancreatic insulin secretion (39, 267, 289).
Since blood sampling was by cardiac puncture, the rats were anesthetized
to minimize any influence of stress on insulin and glucose levels (289,
295, 365).

Table 3 and figure 3 present the basal fasting serum glucose and
insulin levels 4 hours after acute lead administration.

Filkins and

Buchanan verified that RES function is decreased at that time {143).
Serum glucose levels were unchanged and normal [60-120 mg/dl]

(36~yet

serum immunoreactive insulin or IRI showed a statistically significant
elevation in the lead group.

This resulted in an elevation of the insu-

lin to glucose ratio (I/G) which indicates that there was an abnormally
large amount of circulating insulin in the lead-treated rats relative to
the pancreatic glucose stimulus.

This ratio has been shown by Merimee

and Tyson to be superior in the diagnosis and differentiation of hypoglycemia and hyperinsulinemia due to an insulinoma (228).

Both the
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sodium and lead-treated rats had insulin levels within the range of
reported fasting plasma or serum IRI levels of nearly 0

~U/ml

to 66

~U/

ml (51, 162, 289).
Since basal insulin levels were higher in the RES depressed lead
group, the effect of a 5 min glucose stimulation on serum IRI and glucose was investigated.

As shown in table 4 and figure 4 serum insulin

levels were incremented 6-fold in the 4 hr lead treatment group compared
to the sodium control group.

Serum glucose levels were elevated in the

lead-treated rats; however, there was still a 6-fold elevation in the
1/G ratio.

Therefore, the lead-treated rats had markedly elevated serum

insulin levels in relation to the serum glucose concentration present
after glucose administration supporting the data on ba$al insulin and
glucose in table 3 and figure 3.
Rather than choose only one time point in the study on insulin and
glucose levels after colloidal carbon blockade, an attempt was made to
find some correlation between RES function and insulin status.

Basal

serum glucose and insulin levels were measured at 4, 8 and 18 hours
after colloidal carbon blockade and are given in table 5.
mental groups were used in this study:

Three experi-

uninjected control rats, sham

vehicle-injected rats which received a 3 ml iv injection of the vehicle
from the colloidal carbon suspension and the carbon blockade group which
received 32 mg/100 g body weight of colloidal carbon as a 3 ml iv injection.

Although it might be argued that the sham and carbon groups alone

would have been sufficient, the uninjected groups was added to check for
any influences of the injection procedure e.g. stress or possible volume
expansion and to provide normal values.
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At 4 hours after carbon administration, the carbon-group had a
decrease in serum glucose in comparison to the uninjected controls but
not the sham vehicle-injected control group.
explanations for these data.

There are 2 possible

Four hours after a blocking dose of

carbo~

the dose is still being cleared by the RES (227, 370) and the increased
glucose utilization by the actively endocytizing macrophages (2, 8, 45,
70, 208, 210, 264, 265) may cause a lowering of the serum glucose concentration.

The other factor in the sham vehicle-injected rats could be

the 3 ml iv injection of vehicle which contains a fish glue gelatin
(147, 247) protein solution that may remain in the vascular compartment
for several hours.

Dilution may have reduced the 4 hour serum glucose

slightly in the sham group, making the carbon group appear hypoglycemic
compared to only the uninjected rats and not the shams.

The hormonal

systems which maintain blood glucose (124, 281, 360) could also be
acting to counter the lowering of serum glucose by dilution, preventing
an even larger decrease.

Serum insulin levels and the I/G ratio were

elevated in the 4 hr carbon rats compared to the sham rats but not the
uninjected rats (table 5 and figure 5).

In fact the serum insulin

levels in the uninjected rats were higher than those of the sham control
rats.

Again the most likely explanation for the diminished serum in-

sulin levels in the sham vehicle-injected rats is possible dilution of
the circulating insulin.

The albino rat has an estimated blood volume

of about 5 ml/100 g body weight (28, 193, 258).

Since the rats weighed

about 300 g, the blood volume should be approximately 15 ml and, assuming a hematocrit of 45 (28), the plasma or serum volume should be about
8.25 ml.

Therefore, a 3 ml injection of a protein solution couldenlarge
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the plasma volume by up to one-third.
in the sham group, which were 20.9
imately 28

~U/ml

~

For example, the insulin levels
2.9

~U/ml,

might have been approx-

without the injection of vehicle and thus similar to

the uninjected control insulin levels of 32.4

~

4.0.

This dilution

effect may even have lowered the serum IRI in the 4 hr carbon group.
The results of the 4 hour blockade study did not permit any firm conclusions to be made.
Because the 4 hour study hinted of a possible increase in serum
insulin levels in the carbon injected rats, which may have been entering
a state of RES blockade (12, 152, 205, 259, 369), the next study investigated the effect of an 8 hour carbon blockade on serum glucose and
insulin levels.

Several workers have found that at 6 to 12 hours after

a blocking dose of colloidal carbon, RES endocytic activity is depressed
in several species (12, 152, 213, 259, 369, 370).

The results of the

8 hour carbon blockade are displayed in table 5 and figure 6.

'In con-

trast to the 4 hr study, 8 hr carbon blockade resulted in a doubling of
basal fasting serum insulin levels compared to both the sham and uninjected control groups.

The serum glucose levels were unchanged causing

a doubling of the I/G ratio reminiscent of the results in the lead

stud~

After 400 mg of glucose iv, the rats subjected to an 8 hr carbon
blockade had a 3-fold elevation in serum IRI levels.

As in the basal

state, the serum glucose values were similar in all 3 experimental
groups as seen in table 6 and figure 7.

Consequently, the l/G ratios

in the carbon blockade group also showed a 3-fold elevation.

Since

colloidal carbon blockade is the best model for a "pure" RES depressed
state, the results of the basal and glucose stimulation studies clearly
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demonstrated that during RES depression there is an increase in the
circulating serum IRI.

The fact that normal serum glucose levels were

maintained despite the hyperinsulinemic state is not surprising if one
considers that the various components of the glucoregulatory system
(124, 360) may be capable of counteracting the insulin increase.

In

fact these data may indicate that those systems are functional in the
RES depressed animal.

An elevation of glucagon levels could stimulate

pancreatic insulin secretion (360); however, glucagon levels were not
measured in this study preventing any conclusions regarding glucagon's
role in the hyperinsulinemia observed.

Insulin resistance is not a

likely explanation for these data in view of the results of the earlier
studies of RES depression which demonstrated:

1) a decreased resistance

to lethal insulin-induced hypoglycemia (table 1) (52, 55, 142, 144,

263~

2) an enhanced hypoglycemic response to exogenous insulin (52, 142), 3)
increased glucose tolerance (table 2) (144), 4) increased glucose oxidation (56, 134, 144) and utilization (188, 363, 364) and 5) decreased
gluconeogenesis (56, 84, 140, 144, 145, 146, 188, 225, 291).

Since the

RES, especially the Kupffer cells, normally clear the blood of endotoxin
(18, 20, 23, 41, 44, 53, 101, 129, 171, 179, 192, 196, 257, 274, 323,
350, 353, 370), RES hypofunction may foster an endotoxemia (41, 101, 257)
L'''ich would produce the alterations in glucose metabolism and insulin
regulation seen with RES depression.

Unfortunately this possibility

cannot be tested as there is currently no satisfactory method of assaying minute quantities of endotoxin in biological fluids.

The older

bioassay method to detect serum endotoxin was done using RES depressed
animals (53, 135) and the limulus lysate test was reported to have no
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clinical usefulness for detection of endotoxemia (117).
In order to verify that the hyperinsulinemia was a concomitant of
RES depression, blood samples were taken at 18 hours after administration of a blocking dose of colloidal carbon.

Several workers have

noted that from about 18 hours through 4 days after carbon blockade,
there was a recovery of RES function to either a normal or heightened
level of endocytic activity (22, 38, 103, 205, 259, 301, 309, 369).
Table 5 and figure 5 show that at 18 hours after carbon blockade, serum
insulin levels were not significantly different from control levels.
The serum glucose levels and I/G ratios were also similar in the 3
groups.

The fact that serum insulin levels were normal when the RES

function should have been returning to normal along with the preceding
demonstration of hyperinsulinemia during RES depression divorced from
a shock episode support the existence of a relationship between altered
reticuloendotheilial systen1 function and insulin regulation.
Proposed Role of the Reticuloendothelial System in Insulin Regulation.
This study was performed to investigate a relationship between
altered RES function and insulin regulation.

In the two models of RES

depression that were utilized, colloidal carbon blockade and acute lead
treatment, both a functional and an actual hyperinsulemia were demonstrated.

These results suggested a possible role for the RES, particu-

larly the Kupffer cells of the liver, in the modulation of insulin

level~

The hepatic macrophages normally are the principal endocytic cells
of the body as evidenced by clearance studies (36, 179, 276, 309) and
may also be equally important in the metabolism of the body.

Some of

the many metabolic, degradative and secretory functions of macrophages
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were discussed in the literature review.

What follows is a proposition

that the hepatic macrophages may participate in the control of glucose
homeostasis via regulation of

peripheral insulin levels by the pinocy-

tic uptake and degradation of insulin.
All the insulin-rich pancreatic venous effluent enters the portal
vein and then passes through the liver before reaching the other tissues.
During one trans-hepatic passage, Field, Mortimore and others have reported that 40 to 50% of portal venous insulin is removed (47, 133, 202,
236, 237), making the liver the chief site of insulin extraction in the

body (47).

In support of this statement, hyperinsulinemia has been

detected in cirrhotic patients with portal-systemic shunting of blood
and after portocaval anastomosis (197, 294, 297).

Johnston et al. have

presented data suggesting that cirrhosis of the liver causes a peripheral hyperinsulinism by decreased hepatic insulin degradation and not
increased insulin secretion (197).

Both hyperinsulinemia or elevation

of the I/G ratio have also been noted in cases of fulminating hepatitis
(131, 282).

However, despite the numerous investigations of hepatic

insulin handling, the Kupffer cells have not been considered although
they comprise about

33/~

of liver cells (31).

Past investigators of

insulin extraction and degradation tended to regard the liver as a
homogeneous organ composed of only parenchymal cells since they were
the largest cell population in the liver (31)

~'Jhich

was studied lr!_ toto.

Early experiments tested the ability of the liver and other tissue
homogenates to degrade insulin by rendering isotopically labeled insulin trichloroacetic acid-soluble (63, 116, 215, 322, 327, 361 ).

These

studies resulted in the recognition of two types of insulin-degrading
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enzymes.

One type is glutathione-insulin transhydrogenase (GIT) (63,

209, 232, 322, 326, 327, 335, 336, 340), which requires reduced glutathione or other thiol compounds (64, 335) to reduce the disulfide bonds
of insulin, resulting in the separation of the A and B chains.

The

other type of enzyme includes the insulin proteases, which proteolytically degrade the polypeptide chains (50, 57, 215, 322, 337).

Two

studies on the tissue distribution of insulin degrading enzymes demonstrated that the liver possessed a high content of both GIT and insulin
protease (63, 215).

Generally there was an inverse relation between

tissue insulin sensitivity and tissue insulin-degrading activity (63).
The exact location of the insulin degradation process remains
controversial.

Plasma membrane-bound insulin-degrading activity has

been reported (155, 181, 252, 338) but may be an artifact of cell fractionation (338).

However the insulin-degrading enzymes are primarily

intracellular (50, 57, 173, 181, 215, 322, 337).

This results in a

paradox in that the standard model for insulin action at the cellular
level entails reversible binding to an external membrane receptor protein resulting in i ntracell ul ar changes vi a "second messengers" (88,
169, 204, 218) with the bound insulin remaining undegraded (155).

How-

ever Cuatrecasas• clever study to prove that insulin interaction with
superficial cellular receptors initiated insulin•s metabolic effects
(88) has been disproven.

The insulin-sepharose complex that he utilized

has since been shown to dissociate into a super-active free form of insulin when in contact with biological materials (169, 328).

Isolated

intact cells have also been shown to degrade insulin (62, 181, 219, 252,
318, 339), the amount of degradation being directly related to the
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amount bound to the receptor (318).

Thus the receptor may function in

bringing insulin into contact with the degrading systems which then
terminate the hormonal signal at the cell membrane (308, 318).
r~isbin

et

~-

found that insulin extraction by the isolated per-

fused rat liver cannot be explained by the properties of the previously
described insulin-degrading enzymes (233).

Others have noticed that

there is a lag between the initial removal and subsequent degradation
of insulin by both isolated perfused rat liver (194, 236, 319) and rat
hepatocytes (318) that was not seen in the studies using broken-cell or
isolated enzyme preparations (50, 57, 63, 64, 88, 155, 173, 209, 215,
232,252,322,326,327,335,336, 337, 338, 340, 361).

Also factors VJhich

are thought to decrease the mobility of cell membrane components, such
as decreased temperature (2, 83, 240, 273) and concanavalin A (29), have
been shown to depress insulin degradation (236, 318, 319), with little
interference with insulin extraction (236), binding (319) or degradative
enzyme reactions (236).

Numerous reports of intracellular localization

of labeled insulin in intact cells or tissues, after iv injection or in
vitro addition, exist (17, 46, 109, 116, 157,169, 194, 221,232, 252,
307, 322, 366).

Recent studies have uncovered intracellular insulin

receptors (169, 191), implying that insulin may in fact enter cells and
bind to subcellular organelles.

Several investigators have therefore

proposed that the missing link between extracellular binding and intracellular degradation could be the entrace of insulin into the cell (194,
221, 307, 322), perhaps by pinocytosis (15, 169, 170, 232, 308).
The preceding review represents the state, of the art as far as
published research papers on insulin extraction and degradation are con-
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cerned.

It may be that Kupffer cells are the missing link in the ex-

planation of hepatic insulin extraction and degradation.

As was men-

tioned before, these cells are the first hepatic cells to be in contact
with insulin secreted by the pancreas.

Kupffer cells can carry out all

the various endocytic processes i.e. phagocytosis, macropinocytosis and
micropinocytosis (239, 240, 242) which formed the basis for their
classification into the mononuclear phagocyte system with other endocytic
RES cells (158).

It seems reasonable to infer that the Kupffer cells

may participate in hepatic insulin metabolism via a pinocytic mechanism.
Although insulin receptors have not been identified on hepatic macrophages as of yet, they have been found on both monocytes (154, 203, 204,
250, 254, 255, 286) and splenic macrophages (13, 271).

Since macrophage

glucose metabolism appeared to be insulin independent, (165, 174, 264),
one is left with the paradox of avid insulin binding without the
familiar metabolic consequences.

Insulin had been shown to cause some

less orthodox effects in lymphocytes such as increased ATPase activity
(177) and augmentation ofT-lymphocyte-mediated cytotoxicity (315).

In

fact T-lymphocyte insulin receptors appear on the cell concommitant with
cellular transfor'mation and immune activation (217, 315).

Insulin would

thus seem to be involved in regulation of immunological functions.

Bar

and associates have demonstrated that insulin caused inhibition of antibody dependent cytotoxicity in spleen macrophages (13).

This effect may

be mediated by the insulin modulation of macrophage Fe receptor expression (271).
The reports of Rhodes (271) and

Baret~-

(13) both point indirectly

to a possible insulin induction of endocytosis which could be instru-
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mental to the subsequent degradation of insulin by macrophages,
especially the Kupffer cells.

Stossel et

~·

did report that insulin

slightly stimulated the phagocytic rate of polymorphonuclear leukocytes
(314).

Insulin appeared to enter adipose tissue cells (15) and renal

proximal tubule

cells by endocytosis (46).

Incubation of fibroblasts

with insulin resulted in the formation of numerous microvilli on the
cell surface (128, 198).

It could be argued that insulin was merely

promoting the growth of the fibroblasts and causing a pleiotypic
response (187) but insulin has been shown to promote microtubule assembly in cells (262, 300) without significant effects on protein synthesis
(262).

Microtubules and microfilaments probably mediate changes in cell

membrane conformation, especially those associated with endocytosis
(246, 310, 311, 312, 313).

The insulin molecule has minimum solubility

in body fluids at pH= 5.0, suggesting that it exists as an anionic
molecule at physiological pH (162).

Cohn has mentioned in several

papers that anionic molecules tended to stimulate pinocytic activity in
macrophages {71, 72, 76, 113).

Thus insulin may induce endocytosis,

probably pinocytosis in macrophages.
Heightened endocytic activity has been shown to result in a depletion of macrophage cellular membrane components including receptors
(73, 239, 266, 269, 354, 355).

It is then logical to suggest that

insulin receptors may also be internalized during the endocytosis of a
colloidal overload such as a blockade-inducing dose of carbon.

The

down-regulation of insul-in receptors, characterized by a reciprocal
relationship between insulin concentration in the extracellular fluid
and the concentration of cellular insulin receptors (164), may involve
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internalization of the insulin-receptor complex (204, 308).

Kahn et a l .

have discussed the possibility of a pinocytic uptake of the receptor with
its subsequent enzymatic degradation inside the cell (204).

Inhibitors

of protein synthesis prevented the receptor degradation (204).

It seems

probable that these enzymes may be contained in lysosomes which are
abundant in Kupffer cells (2, 25, 241, 299).

Steiner has proposed that

insulin enters intact cells perhaps by endocytosis of an insulin-receptor complex which could then dissociate, allowing the hormone or its
fragments to act directly on cellular components (308).
~·Jallace

Grisolia and

found hepatic lysosomes to be rich in both GIT and

11

insulin

specific protease 11 (173) lending support to a lysosomal theory of degradation of insulin.

Human leukocytes were shown to contain GIT (65), so

monocytes and other RES cells may possess insulin degrading activity.
During the induction of a diabetic state with streptozotocin, wandering
macrophages disposed of the remaining insulin granules within the pancreas (200, 201).

Kupffer ce 11 s have also been reported to take up and

degrade insulin antibody complexes (157, 347) and to concentrate labeled
insulin (17, 307, 366).

A preliminary report by Wagle (347) that

11

much

higher degradation of insulin was found with Kupff'r cells than with
hepatocytes, 11 which appeared after this study was completed, may confirm
the participation of Kupffer cells in the hepatic degradation and thus
modulation of insulin levels.
Even if Kupffer cells are proved to degrade

insulin~

vitro further

experimentation will be needed to elucidate the exact mechanisms of the
cellular uptake and enzymatic activites involved.

In order to deter-

mine whether and what type of endocytosis is involved, studies using
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isolated Kupffer cells and various inhibitors of endocytosis should be
fruitful.

Since insulin is a relatively small molecule, and in solu-

tion, the most likely mechanisms for its uptake by macrophages would be
micropinocytosis, which is inhibited by lmv temperature or decreased
membrane fluidity, or perhaps macropinocytosis, which is inhibited by
cytocha 1as in B and agents interfering with metabolism
sis (2, 70, 72, 113, 240).

m~

protein synthe-

Since Terris and Steiner have reported that

concanavalin A depressed insulin degration in the isolated perfused rat
liver (319), these results may be reinterpreted to support a pinocytic
entrance of insulin into the Kupffer cell with secondary lysosome formation and degradation.

Edelson and Cohn reported that concanavalin A,

rather than inhibit endocytosis (29), stimulated pinosome formation but
prevented fusion of the vesicles with lysosomes (110) rather than
decreasing membrane fluidity (29, 319).
Studies on isolated Kupffer cells should also be done to confirm
whether a GIT-like enzyme for degrading is present.

Glutathione, which

is utilized in the GIT reduction of insulin, is ubiquitous in the body
tissues and is found in high concentration in insulin-degrading tissues
(346).

Glutathione has been shown to be essential to alveolar macro-

phage metabolism (344).

It is probable that macrophages, including

Kupffer cells, do produce glutathione and other thiol containing compounds (66) which could be used to degrade insulin (64, 335).

Since

lead inhibits enzyme systems via combination with sulfhydryl groups
(182) it may interfere with the activity of GIT and insulin degradation
at the molecular level in addition to causing decreased RES endocytic
function.

Cysteine and other sulfhydryl compounds protected rats from
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lead acetate sensitization to endotoxin (34, 79, 80), perhaps by maintaining the normal function of the insulin degradative system.
To verify that RES depression is causing a diminished hepatic extraction and degradation of insulin,studies should be performed using
the isolated perfused liver.

In shock, which is accompanied by RES

depression, i!!_ vivo measurements of insulin clearance showed a prolongation of the half-time of insulin disappearance (61, 87, 226); however,
these results are complicated by a possible decrease in blood flow to
the liver (40).

The in vivo cardiovascular variable would be eliminated

in the isolated organ preparation which would also maintain the Kupffer
cells in their normal condition lining the sinusoids.

There should also

be studies done to determine whether macrophages, especially the hepatic
Kupffer cells, may have a role in insulin regulation by influencing
pancreatic insulin secretion.

Leukocytic endogenous mediator is a pro-

tein reported to be produced during infection by macrophages, as well
as leukocytes (19, 166, 206, 260).

This substance has been shown to

cause elevations in pancreatic insulin via a central nervous systemmediated response (166).

Much clarification of the nature and effects

of this substance is still needed.
The results of the present study and all the above evidence do suggest a potential role for the hepatic Kupffer cells in insulin regulation.

Although not definitively proven, the macrophages of the RES may

interact with insulin not only in terms of regulation of the immune
response (13, 271) but by regulating peripheral insulin levels.

The

Kupffer cells seem especially well-suited for a role in modulating the
amount of insulin presented not only to the peripheral tissues but to
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the parenchymal cells of the liver which control blood glucose levels.
By their maintenance of circulating insulin concentrations which promote a normoglycemic state in the organism, the Kupffer cells would
also insure their own substrate supply.

Consequently, the Kupffer and

parenchymal cells of the liver may function together to insure glucose
homeostasis.
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Conclusions
In summary, the present study demonstrated that:
1.

depression of RES function by acute lead treatment sensitized rats

to lethal insulin-induced hypoglycemia;
2.

RES depression by acute lead administration increased glucose

tolerance;
3.

RES depression by either colloidal carbon blockade or acute lead

administration produced an elevation of both basal and glucose-stimulated serum insulin levels.
Therefore it is concluded that there is a relationship between
altered RES function and insulin regulation since RES depression resulted in a functional and actual hyperinsulinemia.

These data also suggest

a novel role for the RES in the modulation of insulin levels, perhaps by
participation in the hepatic extraction and degradation of insulin.
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